%PDF-1.6
%
1 0 obj
<<
/AcroForm 2 0 R
/MarkInfo <<
/Marked true
>>
/Metadata 3 0 R
/Outlines 4 0 R
/Pages 5 0 R
/StructTreeRoot 6 0 R
/Type /Catalog
>>
endobj
7 0 obj
<<
/Author (Division of Pharmacy)
/CreationDate (D:20200213165157-05'00')
/Creator (Acrobat PDFMaker 19 for Word)
/ModDate (D:20200327121428-04'00')
/Producer (Adobe PDF Library 19.12.68)
/Title (Medicaid DUR Annual Report 2018 - FFS)
>>
endobj
2 0 obj
<<
/DA (/Helv 0 Tf 0 g )
/DR <<
/Encoding <<
/PDFDocEncoding 8 0 R
>>
/Font <<
/HeBo 9 0 R
/Helv 10 0 R
/ZaDb 11 0 R
>>
>>
/Fields [12 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R
22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R
32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R
42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R
52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R
62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R
72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R
82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R 89 0 R 90 0 R 91 0 R
92 0 R 93 0 R 94 0 R 95 0 R 96 0 R 97 0 R 98 0 R 99 0 R 100 0 R 101 0 R
102 0 R 103 0 R 104 0 R 105 0 R 106 0 R 107 0 R 108 0 R 109 0 R 110 0 R 111 0 R
112 0 R 113 0 R 114 0 R 115 0 R 116 0 R 117 0 R 118 0 R 119 0 R 120 0 R 121 0 R
122 0 R 123 0 R 124 0 R 125 0 R 126 0 R 127 0 R 128 0 R 129 0 R 130 0 R 131 0 R
132 0 R 133 0 R 134 0 R 135 0 R 136 0 R 137 0 R 138 0 R 139 0 R 140 0 R 141 0 R
142 0 R 143 0 R 144 0 R 145 0 R 146 0 R 147 0 R 148 0 R 149 0 R 150 0 R 151 0 R
152 0 R 153 0 R 154 0 R 155 0 R 156 0 R 157 0 R 158 0 R 159 0 R 160 0 R 161 0 R
162 0 R 163 0 R 164 0 R 165 0 R 166 0 R 167 0 R 168 0 R 169 0 R 170 0 R 171 0 R
172 0 R 173 0 R 174 0 R 175 0 R 176 0 R 177 0 R 178 0 R 179 0 R 180 0 R 181 0 R
182 0 R 183 0 R 184 0 R 185 0 R 186 0 R 187 0 R 188 0 R 189 0 R 190 0 R 191 0 R
192 0 R 193 0 R 194 0 R 195 0 R 196 0 R 197 0 R 198 0 R 199 0 R 200 0 R 201 0 R
202 0 R 203 0 R 204 0 R 205 0 R 206 0 R 207 0 R 208 0 R 209 0 R 210 0 R 211 0 R
212 0 R 213 0 R 214 0 R 215 0 R 216 0 R 217 0 R 218 0 R 219 0 R 220 0 R 221 0 R
222 0 R 223 0 R 224 0 R 225 0 R 226 0 R 227 0 R 228 0 R 229 0 R 230 0 R 231 0 R
232 0 R 233 0 R 234 0 R 235 0 R 236 0 R 237 0 R 238 0 R 239 0 R 240 0 R 241 0 R
242 0 R 243 0 R 244 0 R 245 0 R 246 0 R 247 0 R 248 0 R 249 0 R 250 0 R 251 0 R
252 0 R 253 0 R 254 0 R 255 0 R 256 0 R 257 0 R 258 0 R 259 0 R 260 0 R 261 0 R
262 0 R 263 0 R 264 0 R 265 0 R 266 0 R 267 0 R 268 0 R 269 0 R 270 0 R 271 0 R
272 0 R 273 0 R 274 0 R 275 0 R 276 0 R 277 0 R 278 0 R 279 0 R 280 0 R 281 0 R
282 0 R 283 0 R 284 0 R 285 0 R 286 0 R 287 0 R 288 0 R 289 0 R 290 0 R 291 0 R
292 0 R 293 0 R 294 0 R 295 0 R 296 0 R 297 0 R 298 0 R 299 0 R 300 0 R 301 0 R
302 0 R 303 0 R 304 0 R 305 0 R 306 0 R 307 0 R 308 0 R 309 0 R 310 0 R 311 0 R
312 0 R 313 0 R 314 0 R 315 0 R 316 0 R 317 0 R 318 0 R 319 0 R 320 0 R 321 0 R
322 0 R 323 0 R 324 0 R 325 0 R 326 0 R 327 0 R 328 0 R 329 0 R 330 0 R 331 0 R
332 0 R 333 0 R 334 0 R 335 0 R 336 0 R 337 0 R 338 0 R 339 0 R 340 0 R 341 0 R
342 0 R 343 0 R 344 0 R 345 0 R 346 0 R 347 0 R 348 0 R 349 0 R 350 0 R 351 0 R
352 0 R 353 0 R 354 0 R 355 0 R 356 0 R 357 0 R 358 0 R 359 0 R 360 0 R 361 0 R
362 0 R 363 0 R 364 0 R 365 0 R 366 0 R 367 0 R 368 0 R 369 0 R 370 0 R 371 0 R
372 0 R 373 0 R 374 0 R 375 0 R 376 0 R 377 0 R 378 0 R 379 0 R 380 0 R 381 0 R
382 0 R 383 0 R 384 0 R 385 0 R 386 0 R 387 0 R 388 0 R 389 0 R 390 0 R 391 0 R]
>>
endobj
3 0 obj
<<
/Length 3663
/Subtype /XML
/Type /Metadata
>>
stream
2020-03-27T12:14:28-04:00
2020-02-13T16:51:57-05:00
2020-03-27T12:14:28-04:00
Acrobat PDFMaker 19 for Word
application/pdf
Medicaid DUR Annual Report 2018 - FFS
Division of Pharmacy
uuid:7bdccae7-2a04-4d18-a262-dc83cdc9ac86
uuid:75bdf1af-37c2-4469-8cf5-68a870a1cb53
Adobe PDF Library 19.12.68
1
1.1
endstream
endobj
4 0 obj
<<
/Count 13
/First 392 0 R
/Last 393 0 R
/Type /Outlines
>>
endobj
5 0 obj
<<
/Count 55
/Kids [394 0 R 395 0 R]
/Type /Pages
>>
endobj
6 0 obj
<<
/K 396 0 R
/ParentTree 397 0 R
/ParentTreeNextKey 56
/RoleMap 398 0 R
/Type /StructTreeRoot
>>
endobj
8 0 obj
<<
/Differences [24 /breve /caron /circumflex /dotaccent /hungarumlaut /ogonek /ring /tilde 39
/quotesingle 96 /grave 128 /bullet /dagger /daggerdbl /ellipsis /emdash /endash
/florin /fraction /guilsinglleft /guilsinglright /minus /perthousand /quotedblbase /quotedblleft /quotedblright /quoteleft
/quoteright /quotesinglbase /trademark /fi /fl /Lslash /OE /Scaron /Ydieresis /Zcaron
/dotlessi /lslash /oe /scaron /zcaron 160 /Euro 164 /currency 166
/brokenbar 168 /dieresis /copyright /ordfeminine 172 /logicalnot /.notdef /registered /macron
/degree /plusminus /twosuperior /threesuperior /acute /mu 183 /periodcentered /cedilla /onesuperior
/ordmasculine 188 /onequarter /onehalf /threequarters 192 /Agrave /Aacute /Acircumflex /Atilde
/Adieresis /Aring /AE /Ccedilla /Egrave /Eacute /Ecircumflex /Edieresis /Igrave /Iacute
/Icircumflex /Idieresis /Eth /Ntilde /Ograve /Oacute /Ocircumflex /Otilde /Odieresis /multiply
/Oslash /Ugrave /Uacute /Ucircumflex /Udieresis /Yacute /Thorn /germandbls /agrave /aacute
/acircumflex /atilde /adieresis /aring /ae /ccedilla /egrave /eacute /ecircumflex /edieresis
/igrave /iacute /icircumflex /idieresis /eth /ntilde /ograve /oacute /ocircumflex /otilde
/odieresis /divide /oslash /ugrave /uacute /ucircumflex /udieresis /yacute /thorn /ydieresis]
/Type /Encoding
>>
endobj
9 0 obj
<<
/BaseFont /Helvetica-Bold
/Encoding 8 0 R
/Name /HeBo
/Subtype /Type1
/Type /Font
>>
endobj
10 0 obj
<<
/BaseFont /Helvetica
/Encoding 8 0 R
/Name /Helv
/Subtype /Type1
/Type /Font
>>
endobj
11 0 obj
<<
/BaseFont /ZapfDingbats
/Name /ZaDb
/Subtype /Type1
/Type /Font
>>
endobj
12 0 obj
<<
/DA (/Helv 8 Tf 0 g)
/FT /Tx
/Ff 4097
/Kids [399 0 R 400 0 R 401 0 R 402 0 R 403 0 R 404 0 R 405 0 R 406 0 R 407 0 R 408 0 R
409 0 R 410 0 R 411 0 R 412 0 R 413 0 R 414 0 R 415 0 R 416 0 R 417 0 R 418 0 R
419 0 R 420 0 R 421 0 R 422 0 R 423 0 R 424 0 R 425 0 R 426 0 R 427 0 R 428 0 R
429 0 R 430 0 R 431 0 R 432 0 R 433 0 R 434 0 R 435 0 R 436 0 R 437 0 R 438 0 R
439 0 R 440 0 R 441 0 R 442 0 R 443 0 R 444 0 R 445 0 R 446 0 R 447 0 R 448 0 R
449 0 R 450 0 R 451 0 R 452 0 R 453 0 R]
/Q 1
/T (ffs_state)
/TU (State)
/V (NEVADA)
>>
endobj
13 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 1
/MK <<
>>
/MaxLen 70
/P 454 0 R
/Rect [251.663 596.573 539.783 622.853]
/Subtype /Widget
/T (S01Q00003)
/TU (Identify state person responsible for DUR Annual Report Preparation. First Name)
/Type /Annot
/V (Holly )
/AP 455 0 R
>>
endobj
14 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 1
/MK <<
>>
/MaxLen 70
/P 454 0 R
/Rect [251.518 568.972 539.638 595.252]
/Subtype /Widget
/T (S01Q00004)
/TU (Last Name)
/Type /Annot
/V (Long)
/AP 456 0 R
>>
endobj
15 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 1
/MK <<
>>
/MaxLen 100
/P 454 0 R
/Rect [251.518 541.434 539.638 567.714]
/Subtype /Widget
/T (S01I00005)
/TU (Email Address)
/Type /Annot
/V (hlong@dhcfp.nv.gov)
/AP 457 0 R
>>
endobj
16 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 1
/MK <<
>>
/MaxLen 12
/P 454 0 R
/Rect [251.518 513.688 539.638 539.968]
/Subtype /Widget
/T (S01I00006)
/TU (Area Code/Phone Number)
/Type /Annot
/V (775-684-3150)
/AP 458 0 R
>>
endobj
17 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 454 0 R
/Q 1
/Rect [125.613 434.653 251.733 460.453]
/Subtype /Widget
/T (S01Q00007)
/TU (On average, how many beneficiaries are enrolled in your state's Medicaid Fee-For-Service \(FFS\) program that have a pharmacy benefit?)
/Type /Annot
/V (185,958)
/AP 459 0 R
>>
endobj
18 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 454 0 R
/Q 1
/Rect [125.613 362.911 251.733 388.71]
/Subtype /Widget
/T (S01Q00008)
/TU (On average, how many of your state's Medicaid beneficiaries are enrolled in managed care plan\(s\)?)
/Type /Annot
/V (481,090)
/AP 460 0 R
>>
endobj
19 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [461 0 R 462 0 R 463 0 R]
/T (S02Q00001)
/TU (Indicate the type of your pharmacy POS vendor.)
/V /Contractor
>>
endobj
20 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 1
/MK <<
>>
/MaxLen 256
/P 454 0 R
/Rect [161.784 165.156 539.001 186.922]
/Subtype /Widget
/T (S02Q0001A)
/TU (Vendor Name)
/Type /Annot
/V (OptumRx)
/AP 464 0 R
>>
endobj
21 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [465 0 R 466 0 R 467 0 R]
/T (S02Q0001B)
/TU (Is the POS vendor also the MMIS fiscal agent?)
/V /POS#20vendor#20is#20a#20separate#20PBM
>>
endobj
22 0 obj
<<
/AP <<
/D <<
/Off 468 0 R
/On 469 0 R
>>
/N <<
/On 470 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 471 0 R
/Rect [126.338 557.523 139.658 567.963]
/Subtype /Widget
/T (S02Q00002_20119)
/TU (Identify prospective DUR criteria source. First Databank)
/Type /Annot
/V /Off
>>
endobj
23 0 obj
<<
/AP <<
/D <<
/Off 472 0 R
/On 473 0 R
>>
/N <<
/On 474 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 471 0 R
/Rect [126.338 536.523 139.658 546.963]
/Subtype /Widget
/T (S02Q00002_20120)
/TU (Identify prospective DUR criteria source. First Data Bank)
/Type /Annot
/V /On
>>
endobj
24 0 obj
<<
/AP <<
/D <<
/Off 475 0 R
/On 476 0 R
>>
/N <<
/On 477 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 471 0 R
/Rect [126.338 516.523 139.658 526.963]
/Subtype /Widget
/T (S02Q00002_20121)
/TU (Identify prospective DUR criteria source. First Data Bank)
/Type /Annot
/V /Off
>>
endobj
25 0 obj
<<
/AP <<
/D <<
/Off 478 0 R
/On 479 0 R
>>
/N <<
/On 480 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 471 0 R
/Rect [126.338 496.523 139.658 506.962]
/Subtype /Widget
/T (S02Q00002_20122)
/TU (Identify prospective DUR criteria source. First Data Bank)
/Type /Annot
/V /Off
>>
endobj
26 0 obj
<<
/AP <<
/N 481 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 471 0 R
/Rect [148.099 392.335 543.172 465.514]
/Subtype /Widget
/T (S02Q0002O)
/TU (Please specify for "Other.")
/Type /Annot
>>
endobj
27 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [482 0 R 483 0 R]
/T (S02Q00003)
/TU (Are new ProDUR criteria approved by the DUR Board?)
/V /No
>>
endobj
28 0 obj
<<
/AP <<
/N 484 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 471 0 R
/Rect [148.094 215.286 544.762 287.413]
/Subtype /Widget
/T (S02Q0003N)
/TU (Please explain for "No.")
/Type /Annot
/V (Medi-Span provides the ProDUR criteria for the State of Nevada. The DUR Board does not review or approve the ProDUR criteria. )
>>
endobj
29 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [485 0 R 486 0 R 487 0 R]
/T (S02Q00004)
/TU <5768656E2074686520706861726D61636973742072656365697665732061206C6576656C2D6F6E652050726F44555220616C657274206D6573736167652074686174207265717569726573206120706861726D61636973742773207265766965772C20646F657320796F75722073797374656D20616C6C6F772074686520706861726D616369737420746F206F766572726964652074686520616C657274207573696E6720746865208D4E43504450206472756720757365206576616C756174696F6E20636F6465738E2028726561736F6E20666F7220736572766963652C2070726F66657373696F6E616C207365727669636520616E64207265736F6C7574696F6E293F>
/V /Yes
>>
endobj
30 0 obj
<<
/AP <<
/N 488 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 489 0 R
/Rect [147.803 496.118 541.567 568.245]
/Subtype /Widget
/T (S02Q0004P)
/TU (Explanation for Partial.)
/Type /Annot
>>
endobj
31 0 obj
<<
/AP <<
/D <<
/Off 490 0 R
/On 491 0 R
>>
/N <<
/On 492 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 489 0 R
/Rect [162.265 352.582 175.945 362.662]
/Subtype /Widget
/T (S02Q005YA_20127)
/TU (How Often?)
/Type /Annot
/V /Off
>>
endobj
32 0 obj
<<
/AP <<
/D <<
/Off 493 0 R
/On 494 0 R
>>
/N <<
/On 495 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 489 0 R
/Rect [161.942 329.226 175.622 339.306]
/Subtype /Widget
/T (S02Q005YA_20128)
/TU (How Often?)
/Type /Annot
/V /Off
>>
endobj
33 0 obj
<<
/AP <<
/D <<
/Off 496 0 R
/On 497 0 R
>>
/N <<
/On 498 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 489 0 R
/Rect [161.942 306.234 175.622 316.313]
/Subtype /Widget
/T (S02Q005YA_20129)
/TU (How Often?)
/Type /Annot
/V /Off
>>
endobj
34 0 obj
<<
/AP <<
/D <<
/Off 499 0 R
/On 500 0 R
>>
/N <<
/On 501 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 489 0 R
/Rect [161.942 283.052 175.622 293.132]
/Subtype /Widget
/T (S02Q005YA_20130)
/TU (How Often?)
/Type /Annot
/V /Off
>>
endobj
35 0 obj
<<
/AP <<
/N 502 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 489 0 R
/Rect [181.892 186.42 542.454 241.076]
/Subtype /Widget
/T (S02Q05YA1)
/TU (If "Other" is selected for "How Often?", please explain.)
/Type /Annot
>>
endobj
36 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [503 0 R 504 0 R 505 0 R]
/T (S02Q0006B)
/TU (For non-controlled drugs, when an early refill message occurs, does the state require prior authorization?)
/V /Yes
>>
endobj
37 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [506 0 R 507 0 R 508 0 R]
/T (S02Q006BY)
/TU <49662074686520616E7377657220746F2061626F76652028366229206973208D5965732C8E2077686F206F627461696E7320617574686F72697A6174696F6E3F>
/V /Pharmacist#20or#20Prescriber
>>
endobj
38 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [509 0 R 510 0 R]
/T (S02Q006BN)
/TU <49662074686520616E7377657220746F2061626F76652028366229206973208D4E6F2C8E2063616E2074686520706861726D6163697374206F766572726964652061742074686520706F696E74206F6620736572766963653F>
>>
endobj
39 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [511 0 R 512 0 R]
/T (S02Q0006C)
/TU (For controlled drugs, when an early refill message occurs, does the state require prior authorization?)
/V /Yes
>>
endobj
40 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [513 0 R 514 0 R 515 0 R]
/T (S02Q006CY)
/TU <49662074686520616E7377657220746F2061626F76652028366329206973208D5965732C8E2077686F206F627461696E7320617574686F72697A6174696F6E3F>
/V /Pharmacist#20or#20Prescriber
>>
endobj
41 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [516 0 R 517 0 R]
/T (S02Q006CN)
/TU <49662074686520616E7377657220746F2061626F76652028366329206973208D4E6F2C8E2063616E2074686520706861726D6163697374206F766572726964652061742074686520706F696E74206F6620736572766963653F>
>>
endobj
42 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [518 0 R 519 0 R 520 0 R]
/T (S02Q0007A)
/TU (Lost/stolen Rx)
/V /No
>>
endobj
43 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [521 0 R 522 0 R 523 0 R]
/T (S02Q0007B)
/TU (Vacation)
/V /No
>>
endobj
44 0 obj
<<
/AP <<
/N 524 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 525 0 R
/Rect [161.587 352.221 559.895 413.683]
/Subtype /Widget
/T (S02Q0007O)
/TU (If No is selected for receiving or reviewing of follow-up periodic reports, please explain.)
/Type /Annot
>>
endobj
45 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [526 0 R 527 0 R]
/T (S02Q00008)
/TU (Does your system have an accumulation edit to prevent patients from continuously filling prescriptions early?)
/V /No
>>
endobj
46 0 obj
<<
/AP <<
/N 528 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 525 0 R
/Rect [146.323 141.627 541.778 209.658]
/Subtype /Widget
/T (S02Q0008Y)
/TU (If "Yes," please explain your edits.)
/Type /Annot
>>
endobj
47 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [529 0 R 530 0 R]
/T (S02Q0008N)
/TU <4966208D4E6F2C8E20646F20796F7520706C616E20746F20696D706C656D656E7420746869732065646974>
/V /No
>>
endobj
48 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [531 0 R 532 0 R]
/T (S02Q00009)
/TU (Does the state Medicaid agency or the state's Board of Pharmacy have any policy prohibiting the auto-refill process that occurs at the POS \(i.e. must obtain beneficiary's consent prior to enrolling in the auto-refill program\)?)
/V /No
>>
endobj
49 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [533 0 R 534 0 R]
/T (S02Q00010)
/TU (Does the state Medicaid agency have any policy that provides for the synchronization of prescription refills \(i.e. if the patient wants and pharmacy provider permits the patient to obtain non-controlled, chronic medication refills at the same time, the state would allow this to occur to prevent the beneficiary from making multiple trips to the pharmacy within the same month\)?)
/V /Yes
>>
endobj
50 0 obj
<<
/AP <<
/N 535 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 536 0 R
/Rect [147.566 541.566 543.021 609.597]
/Subtype /Widget
/T (S02Q0014Y)
/TU (What is the preauthorization process?)
/Type /Annot
/V (The prescribing provider may fax or call the OptumRx Prior Authorization Call Center to request authorization. Medicaid Services Manual \(MSM\) Chapter 1200 - Prescribed Drugs includes criteria which states that drugs not on the PDL, but within drug classes reviewed by the Silver State Scripts Board \(formerly known as the P&T Committee\), require prior authorization, unless exempt under NRS or federal law or excluded through recommendations of the Silver State Scripts Board or excluded by DHCFP. New pharmaceutical products not within reviewed PDL drug classes and not excluded under the state plan or by NRS are covered without a Standard Preferred Drug List Criteria. )
>>
endobj
51 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [537 0 R 538 0 R]
/T (S02Q00014)
/TU (Does the state Medicaid agency have any policy that provides for the synchronization of prescription refills \(i.e. if the patient wants and pharmacy provider permits the patient to obtain non-controlled, chronic medication refills at the same time, the state would allow this to occur to prevent the beneficiary from making multiple trips to the pharmacy within the same month\)?)
/V /Yes
>>
endobj
52 0 obj
<<
/AP <<
/N 539 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 536 0 R
/Rect [148.115 396.494 543.57 464.525]
/Subtype /Widget
/T (S02Q0014N)
/TU (What is the preauthorization process?)
/Type /Annot
>>
endobj
53 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [540 0 R 541 0 R]
/T (S02Q0014A)
/TU (Does your program provide for the dispensing of at least a 72-hour supply of a covered outpatient prescription drug in an emergency situation?)
/V /Yes
>>
endobj
54 0 obj
<<
/AP <<
/N 542 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 536 0 R
/Rect [175.483 214.956 570.938 282.987]
/Subtype /Widget
/T (S02Q014AY)
/TU (What is the process?)
/Type /Annot
/V (The pharmacy may call the OptumRx Call Center to request up to a 96-hour emergency situation coverage. )
>>
endobj
55 0 obj
<<
/AP <<
/N 543 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 536 0 R
/Rect [174.727 98.423 570.182 166.454]
/Subtype /Widget
/T (S02Q014AN)
/TU (Please explain.)
/Type /Annot
>>
endobj
56 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.6842 516.083 258.555 554.363]
/Subtype /Widget
/T (S02QC1R01)
/TU (Top 1 PA Request by Drug Name)
/Type /Annot
/V (Oxycodone HCl Tabs)
/AP 545 0 R
>>
endobj
57 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.606 516.24 410.947 554.4]
/Subtype /Widget
/T (S02QC2R01)
/TU (Top 1 PA Request by Drug Class)
/Type /Annot
/V (Analgesics)
/AP 546 0 R
>>
endobj
58 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [413.186 515.655 598.642 553.815]
/Subtype /Widget
/T (S02QC3R01)
/TU (Top 1 Claim Denial Reason Other Than Eligibility)
/Type /Annot
/V (product/service not covered - plan/benefit exclusion)
/AP 547 0 R
>>
endobj
59 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.693 516.24 786.186 554.4]
/Subtype /Widget
/T (S02QC4R01)
/TU (Top 1 Drug Name by Amount Paid)
/Type /Annot
/V (Antihemophilic Factor RAHF-PFM)
/AP 548 0 R
>>
endobj
60 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.536 516.24 850.136 554.4]
/Subtype /Widget
/T (S02QC5R01)
/TU (% of Total Spent for Top 1 Drug by Amount Paid)
/Type /Annot
/V (6.96)
/AP 549 0 R
>>
endobj
61 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [868.902 516.24 1051.19 554.4]
/Subtype /Widget
/T (S02QC6R01)
/TU (Top 1 Drug Name by Claim Count)
/Type /Annot
/V (Albuterol Sulfate/ipratropium bromide)
/AP 550 0 R
>>
endobj
62 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.34 516.24 1113.94 554.4]
/Subtype /Widget
/T (S02QC7R01)
/TU (Top 1 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (2.59)
/AP 551 0 R
>>
endobj
63 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.88 468.868 258.48 507.148]
/Subtype /Widget
/T (S02QC1R02)
/TU (Top 2 PA Request by Drug Name)
/Type /Annot
/V (Guanfacine HCl Tabs \(ADHD\) Tb24)
/AP 552 0 R
>>
endobj
64 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.96 468.72 411.12 506.88]
/Subtype /Widget
/T (S02QC2R02)
/TU (Top 2 PA Request by Drug Class)
/Type /Annot
/V (ADHD/Anti-Narcolepsy/Anti-Obesity/Anorexiants)
/AP 553 0 R
>>
endobj
65 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [413.28 468.72 598.32 506.88]
/Subtype /Widget
/T (S02QC3R02)
/TU (Top 2 Claim Denial Reason Other Than Eligibility)
/Type /Annot
/V (dur reject error)
/AP 554 0 R
>>
endobj
66 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.8 468.72 786.24 506.88]
/Subtype /Widget
/T (S02QC4R02)
/TU (Top 2 Drug Name by Amount Paid)
/Type /Annot
/V (Coagulation Factor VIIa \(Recombinant\))
/AP 555 0 R
>>
endobj
67 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.72 468.72 850.32 506.88]
/Subtype /Widget
/T (S02QC5R02)
/TU (% of Total Spent for Top 2 Drug by Amount Paid)
/Type /Annot
/V (4.05)
/AP 556 0 R
>>
endobj
68 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [869.04 468.72 1051.2 506.88]
/Subtype /Widget
/T (S02QC6R02)
/TU (Top 2 Drug Name by Claim Count)
/Type /Annot
/V (Hydrocodone-Acetaminophen)
/AP 557 0 R
>>
endobj
69 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.24 468.72 1113.84 506.88]
/Subtype /Widget
/T (S02QC7R02)
/TU (Top 2 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (2.12)
/AP 558 0 R
>>
endobj
70 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.88 422.446 258.48 460.726]
/Subtype /Widget
/T (S02QC1R03)
/TU (Top 3 PA Request by Drug Name)
/Type /Annot
/V (Amphetamine-Dextroamphetamine Cap SR 24hr)
/AP 559 0 R
>>
endobj
71 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.96 422.64 411.12 460.8]
/Subtype /Widget
/T (S02QC2R03)
/TU (Top 3 PA Request by Drug Class)
/Type /Annot
/V (Antiasthmatic and Bronchodilator Agents)
/AP 560 0 R
>>
endobj
72 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [413.28 422.64 598.32 460.8]
/Subtype /Widget
/T (S02QC3R03)
/TU (Top 3 Claim Denial Reason Other Than Eligibility)
/Type /Annot
/V (prior authorization required)
/AP 561 0 R
>>
endobj
73 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.8 422.64 786.24 460.8]
/Subtype /Widget
/T (S02QC4R03)
/TU (Top 3 Drug Name by Amount Paid)
/Type /Annot
/V (Paliperidone Palmitate )
/AP 562 0 R
>>
endobj
74 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.72 422.64 850.32 460.8]
/Subtype /Widget
/T (S02QC5R03)
/TU (% of Total Spent for Top 3 Drug by Amount Paid)
/Type /Annot
/V (2.12)
/AP 563 0 R
>>
endobj
75 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [869.04 422.64 1051.2 460.8]
/Subtype /Widget
/T (S02QC6R03)
/TU (Top 3 Drug Name by Claim Count)
/Type /Annot
/V (Gabapentin)
/AP 564 0 R
>>
endobj
76 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.24 422.64 1113.84 460.8]
/Subtype /Widget
/T (S02QC7R03)
/TU (Top 3 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (2.12)
/AP 565 0 R
>>
endobj
77 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.88 373.526 258.48 411.926]
/Subtype /Widget
/T (S02QC1R04)
/TU (Top 4 PA Request by Drug Name)
/Type /Annot
/V (Omeprazole CPDR)
/AP 566 0 R
>>
endobj
78 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.96 373.68 411.12 411.84]
/Subtype /Widget
/T (S02QC2R04)
/TU (Top 4 PA Request by Drug Class)
/Type /Annot
/V (Ulcer Drugs/Antispasmodics/Anticholinergics)
/AP 567 0 R
>>
endobj
79 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [413.28 373.68 598.32 411.84]
/Subtype /Widget
/T (S02QC3R04)
/TU (Top 4 Claim Denial Reason Other Than Eligibility)
/Type /Annot
/V (plan limitations exceeded)
/AP 568 0 R
>>
endobj
80 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.8 373.68 786.24 411.84]
/Subtype /Widget
/T (S02QC4R04)
/TU (Top 4 Drug Name by Amount Paid)
/Type /Annot
/V (Lurasidone HCl)
/AP 569 0 R
>>
endobj
81 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.72 373.68 850.32 411.84]
/Subtype /Widget
/T (S02QC5R04)
/TU (% of Total Spent for Top 4 Drug by Amount Paid)
/Type /Annot
/V (1.72)
/AP 570 0 R
>>
endobj
82 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [869.04 373.68 1051.2 411.84]
/Subtype /Widget
/T (S02QC6R04)
/TU (Top 4 Drug Name by Claim Count)
/Type /Annot
/V (Atorvastatin Calcium)
/AP 571 0 R
>>
endobj
83 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.24 373.68 1113.84 411.84]
/Subtype /Widget
/T (S02QC7R04)
/TU (Top 4 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (1.71)
/AP 572 0 R
>>
endobj
84 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.88 324.726 258.48 363.006]
/Subtype /Widget
/T (S02QC1R05)
/TU (Top 5 PA Request by Drug Name)
/Type /Annot
/V (Lisdexamfetamine Dimesylate Caps)
/AP 573 0 R
>>
endobj
85 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.96 324.72 411.12 362.88]
/Subtype /Widget
/T (S02QC2R05)
/TU (Top 5 PA Request by Drug Class)
/Type /Annot
/V (Dermatologicals)
/AP 574 0 R
>>
endobj
86 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [413.28 324.72 598.32 362.88]
/Subtype /Widget
/T (S02QC3R05)
/TU (Top 5 Claim Denial Reason Other Than Eligibility)
/Type /Annot
/V (Missing/Invalid Quantity Dispensed)
/AP 575 0 R
>>
endobj
87 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.8 324.72 786.24 362.88]
/Subtype /Widget
/T (S02QC4R05)
/TU (Top 5 Drug Name by Amount Paid)
/Type /Annot
/V (Antihemophilic Factor \(Recombinant\))
/AP 576 0 R
>>
endobj
88 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.72 324.72 850.32 362.88]
/Subtype /Widget
/T (S02QC5R05)
/TU (% of Total Spent for Top 5 Drug by Amount Paid)
/Type /Annot
/V (1.72)
/AP 577 0 R
>>
endobj
89 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [869.04 324.72 1051.2 362.88]
/Subtype /Widget
/T (S02QC6R05)
/TU (Top 5 Drug Name by Claim Count)
/Type /Annot
/V (Ibuprofen)
/AP 578 0 R
>>
endobj
90 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.24 324.72 1113.84 362.88]
/Subtype /Widget
/T (S02QC7R05)
/TU (Top 5 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (1.6)
/AP 579 0 R
>>
endobj
91 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.88 279.096 258.48 317.376]
/Subtype /Widget
/T (S02QC1R06)
/TU (Top 6 PA Request by Drug Name)
/Type /Annot
/V (Zolpidem Tartrate Tabs)
/AP 580 0 R
>>
endobj
92 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.96 279.36 411.12 317.52]
/Subtype /Widget
/T (S02QC2R06)
/TU (Top 6 PA Request by Drug Class)
/Type /Annot
/V (Hypnotics/Sedatives/Sleep Disorder Agents)
/AP 581 0 R
>>
endobj
93 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.8 279.36 786.24 317.52]
/Subtype /Widget
/T (S02QC4R06)
/TU (Top 6 Drug Name by Amount Paid)
/Type /Annot
/V (adalimumab)
/AP 582 0 R
>>
endobj
94 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.72 279.36 850.32 317.52]
/Subtype /Widget
/T (S02QC5R06)
/TU (Top 5 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (1.56)
/AP 583 0 R
>>
endobj
95 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [869.04 279.36 1051.2 317.52]
/Subtype /Widget
/T (S02QC6R06)
/TU (Top 6 Drug Name by Claim Count)
/Type /Annot
/V (lisinopril)
/AP 584 0 R
>>
endobj
96 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.24 279.36 1113.84 317.52]
/Subtype /Widget
/T (S02QC7R06)
/TU (Top 6 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (1.27)
/AP 585 0 R
>>
endobj
97 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.88 232.674 258.48 270.955]
/Subtype /Widget
/T (S02QC1R07)
/TU (Top 7 PA Request by Drug Name)
/Type /Annot
/V (Methylphenidate HCl TBCR)
/AP 586 0 R
>>
endobj
98 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.96 232.56 411.12 270.72]
/Subtype /Widget
/T (S02QC2R07)
/TU (Top 7 PA Request by Drug Class)
/Type /Annot
/V (Antipsychotics/Antimanic Agents)
/AP 587 0 R
>>
endobj
99 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.8 232.56 786.24 270.72]
/Subtype /Widget
/T (S02QC4R07)
/TU (Top 7 Drug Name by Amount Paid)
/Type /Annot
/V (Insulin Glargine)
/AP 588 0 R
>>
endobj
100 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.72 232.56 850.32 270.72]
/Subtype /Widget
/T (S02QC5R07)
/TU (% of Total Spent for Top 7 Drug by Amount Paid)
/Type /Annot
/V (1.23)
/AP 589 0 R
>>
endobj
101 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [869.04 232.56 1051.2 270.72]
/Subtype /Widget
/T (S02QC6R07)
/TU (Top 7 Drug Name by Claim Count)
/Type /Annot
/V (Quetiapine FumarateTrazodone HCl)
/AP 590 0 R
>>
endobj
102 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.24 232.56 1113.84 270.72]
/Subtype /Widget
/T (S02QC7R07)
/TU (Top 7 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (1.27)
/AP 591 0 R
>>
endobj
103 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.88 184.667 258.48 222.947]
/Subtype /Widget
/T (S02QC1R08)
/TU (Top 8 PA Request by Drug Name)
/Type /Annot
/V (Morphine Sulfate TBCR)
/AP 592 0 R
>>
endobj
104 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.96 184.32 411.12 223.2]
/Subtype /Widget
/T (S02QC2R08)
/TU (Top 8 PA Request by Drug Class)
/Type /Annot
/V (Antidepressants)
/AP 593 0 R
>>
endobj
105 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.8 184.32 786.24 223.2]
/Subtype /Widget
/T (S02QC4R08)
/TU (Top 8 Drug Name by Amount Paid)
/Type /Annot
/V (Albuterol Sulfate/ipratropium bromide)
/AP 594 0 R
>>
endobj
106 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.72 184.32 850.32 223.2]
/Subtype /Widget
/T (S02QC5R08)
/TU (% of Total Spent for Top 8 Drug by Amount Paid)
/Type /Annot
/V (1.22)
/AP 595 0 R
>>
endobj
107 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [869.04 184.32 1051.2 223.2]
/Subtype /Widget
/T (S02QC6R08)
/TU (Top 8 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (Trazodone HCl)
/AP 596 0 R
>>
endobj
108 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.24 184.32 1113.84 223.2]
/Subtype /Widget
/T (S02QC7R08)
/TU (Top 8 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (1.23)
/AP 597 0 R
>>
endobj
109 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.88 136.66 258.48 174.94]
/Subtype /Widget
/T (S02QC1R09)
/TU (Top 9 PA Request by Drug Name)
/Type /Annot
/V (Buprenorphine HCl-Naloxone HCl Dihydrate Film)
/AP 598 0 R
>>
endobj
110 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.96 136.8 411.12 174.96]
/Subtype /Widget
/T (S02QC2R09)
/TU (Top 9 PA Request by Drug Class)
/Type /Annot
/V (Anticonvulsants)
/AP 599 0 R
>>
endobj
111 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.8 136.8 786.24 174.96]
/Subtype /Widget
/T (S02QC4R09)
/TU (Top 9 Drug Name by Amount Paid)
/Type /Annot
/V (Sofosbuvir-Velpatasvir)
/AP 600 0 R
>>
endobj
112 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.72 136.8 850.32 174.96]
/Subtype /Widget
/T (S02QC5R09)
/TU (% of Total Spent for Top 9 Drug by Amount Paid)
/Type /Annot
/V (1.13)
/AP 601 0 R
>>
endobj
113 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [869.04 136.8 1051.2 174.96]
/Subtype /Widget
/T (S02QC6R09)
/TU (Top 9 Drug Name by Claim Count)
/Type /Annot
/V (Ondansetron HCl)
/AP 602 0 R
>>
endobj
114 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.24 136.8 1113.84 174.96]
/Subtype /Widget
/T (S02QC7R09)
/TU (Top 9 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (1.21)
/AP 603 0 R
>>
endobj
115 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [74.88 87.7394 258.48 126.14]
/Subtype /Widget
/T (S02QC1R10)
/TU (Top 10 PA Request by Drug Name)
/Type /Annot
/V (Albuterol Sulfate Aers)
/AP 604 0 R
>>
endobj
116 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [264.96 87.84 411.12 126.0]
/Subtype /Widget
/T (S02QC2R10)
/TU (Top 10 PA Request by Drug Class)
/Type /Annot
/V (Gastrointestinal Agents - Misc.)
/AP 605 0 R
>>
endobj
117 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [604.8 87.84 786.24 126.0]
/Subtype /Widget
/T (S02QC4R10)
/TU (Top 10 Drug Name by Amount Paid)
/Type /Annot
/V (Aripiprazole)
/AP 606 0 R
>>
endobj
118 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [792.72 87.84 850.32 126.0]
/Subtype /Widget
/T (S02QC5R10)
/TU (% of Total Spent for Top 10 Drug by Amount Paid)
/Type /Annot
/V (0.99)
/AP 607 0 R
>>
endobj
119 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 256
/P 544 0 R
/Rect [869.04 87.84 1051.2 126.0]
/Subtype /Widget
/T (S02QC6R10)
/TU (Top 10 Drug Name by Claim Count)
/Type /Annot
/V (Levothyroxine Sodium)
/AP 608 0 R
>>
endobj
120 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/MaxLen 6
/P 544 0 R
/Q 2
/Rect [1056.24 87.84 1113.84 126.0]
/Subtype /Widget
/T (S02QC7R10)
/TU (Top 10 Drug by Claim Count % of Total Claims)
/Type /Annot
/V (1.2)
/AP 609 0 R
>>
endobj
121 0 obj
<<
/AP <<
/D <<
/Off 610 0 R
/On 611 0 R
>>
/N <<
/On 612 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 613 0 R
/Rect [127.069 650.803 139.477 661.243]
/Subtype /Widget
/T (S02Q00012_20018)
/TU (ection 1927\(g\)\(A\) of the Social Security Act requires that the pharmacist offer patient counseling at the time of dispensing. Who in your state has responsibility for monitoring compliance with the oral counseling requirement? Check all that apply: Medicaid agency)
/Type /Annot
/V /Off
>>
endobj
122 0 obj
<<
/AP <<
/D <<
/Off 614 0 R
/On 615 0 R
>>
/N <<
/On 616 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 613 0 R
/Rect [126.156 629.843 139.476 640.283]
/Subtype /Widget
/T (S02Q00012_20019)
/TU (State Board of Pharmacy)
/Type /Annot
/V /On
>>
endobj
123 0 obj
<<
/AP <<
/D <<
/Off 617 0 R
/On 618 0 R
>>
/N <<
/On 619 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 613 0 R
/Rect [126.156 608.939 139.476 619.379]
/Subtype /Widget
/T (S02Q00012_20020)
/TU (Other)
/Type /Annot
/V /Off
>>
endobj
124 0 obj
<<
/AP <<
/N 620 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 613 0 R
/Rect [148.099 508.438 543.172 581.607]
/Subtype /Widget
/T (S02Q0012O)
/TU (Please explain for "Other.")
/Type /Annot
>>
endobj
125 0 obj
<<
/AP <<
/N 621 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 613 0 R
/Rect [125.317 91.4938 544.965 308.942]
/Subtype /Widget
/T (S02Q0013B)
/TU (Summary 1 - Pharmacy Oral Counseling Compliance Report)
/Type /Annot
/V (The State of Nevada Medicaid Program relies on the State Board of Pharmacy to audit pharmacist/pharmacy compliance with the oral counseling requirement. The Nevada State Board of Pharmacy includes adherence with counseling requirements as part of each annual pharmacy inspection. In addition, during any investigation of an incident or patient complaint, counseling records are checked by the inspector.)
>>
endobj
126 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [622 0 R 623 0 R 624 0 R]
/T (S03Q0001B)
/TU (Organization Type)
/V /Company
>>
endobj
127 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 1
/MK <<
>>
/MaxLen 300000
/P 625 0 R
/Rect [139.908 537.074 542.643 563.353]
/Subtype /Widget
/T (S03Q0001A)
/TU (Organization Name)
/Type /Annot
/V (OptumRx)
/AP 626 0 R
>>
endobj
128 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [627 0 R 628 0 R]
/T (S03Q001BA)
/TU (Is the RetroDUR vendor also the MMIS fiscal agent?)
/V /No
>>
endobj
129 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [629 0 R 630 0 R]
/T (S03Q001BB)
/TU (Is the RetroDUR vendor also the developer/supplier of your retrospective DUR criteria?)
/V /Yes
>>
endobj
130 0 obj
<<
/AP <<
/N 631 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 625 0 R
/Rect [162.368 238.151 557.441 311.32]
/Subtype /Widget
/T (S03Q01BBN)
/TU (If "No," please explain.)
/Type /Annot
>>
endobj
131 0 obj
<<
/AP <<
/D <<
/Off 632 0 R
/On 633 0 R
>>
/N <<
/On 634 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 635 0 R
/Rect [126.795 680.167 139.202 690.607]
/Subtype /Widget
/T (S03Q00002_20568)
/TU (Who reviews and approves the RetroDUR criteria?)
/Type /Annot
/V /Off
>>
endobj
132 0 obj
<<
/AP <<
/D <<
/Off 636 0 R
/On 637 0 R
>>
/N <<
/On 638 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 635 0 R
/Rect [126.493 659.104 138.733 669.904]
/Subtype /Widget
/T (S03Q00002_20569)
/TU (Who reviews and approves the RetroDUR criteria?)
/Type /Annot
/V /Off
>>
endobj
133 0 obj
<<
/AP <<
/D <<
/Off 639 0 R
/On 640 0 R
>>
/N <<
/On 641 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 635 0 R
/Rect [126.475 638.458 138.715 649.258]
/Subtype /Widget
/T (S03Q00002_20570)
/TU (Who reviews and approves the RetroDUR criteria?)
/Type /Annot
/V /On
>>
endobj
134 0 obj
<<
/AP <<
/N 642 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 635 0 R
/Rect [148.754 535.158 542.518 607.285]
/Subtype /Widget
/T (S03Q0002O)
/TU (Please explain for No.)
/Type /Annot
/V (The DUR Board offers topics and reviews but does not approve the letters and final initiatives. )
>>
endobj
135 0 obj
<<
/AP <<
/N 643 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 635 0 R
/Rect [124.179 77.7455 543.31 422.576]
/Subtype /Widget
/T (S03Q0003B)
/TU (Summary 2 - Retrospective DUR Educational Outreach)
/Type /Annot
/V <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>
>>
endobj
136 0 obj
<<
/AP <<
/N 644 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 645 0 R
/Rect [124.764 66.989 543.896 411.819]
/Subtype /Widget
/T (S04Q0001B)
/TU (Summary 3 - DUR Board Activities Report)
/Type /Annot
/V <4E6576616461204D656469636169642068656C6420666F7572206D656574696E6773206265747765656E204F63746F62657220312C203230313820616E642053657074656D6265722033302C20323031392E2020466F722070726F73706563746976652044555220616E6420726574726F7370656374697665204455522C207468652044555220426F6172642063616E207265636F6D6D656E64207570646174657320616E64206368616E67657320746F20696E6974696174697665732C20706F6C696369657320616E6420656475636174696F6E2E2020546865204F7074756D52782044555220506861726D61636973742070726F766964657320656475636174696F6E20616E64207265736F757263657320746F2070726F766964657273207468726F75676820726574726F73706563746976652044555220696E6974696174697665732E20205468652044555220426F61726420646964206E6F742065737461626C697368206E657720706F6C6963696573206173206120726573756C74206F662070726F7370656374697665206F7220726574726F7370656374697665204455522073637265656E696E67732E20200A42656C6F7720697320612073756D6D617279206F662065616368206D656574696E672E2020090A0A4F63746F6265722031382C20323031380A436C696E6963616C2050726573656E746174696F6E7320616E6420426F6172642044697363757373696F6E3A0A09496D6D756E6F6D6F64756C61746F722044727567733B204164646974696F6E206F6620637269746572696120666F7220496C756D7961200A094F70696F69647320537065636966696320746F20526563697069656E747320556E646572203138205965617273206F66204167653B2064656372656173652064617920737570706C7920746F207468726565206461797320666F7220726563697069656E747320756E64657220616765203138200A0943616C6369746F6E696E2047656E652D52656C617465642050657074696465205265636570746F722028434752502920496E68696269746F72733B206164646974696F6E206F66206E657720637269746572696120200A426F617264205265706F7274733A0A094869676820446F6C6C617220436C61696D732028436C61696D73206F766572202431302C303030290A09546F70204F70696F6964205574696C697A6174696F6E206279205072657363726962657220616E64204D656D6265720A09416E746962696F746963205574696C697A6174696F6E0A094F6E636F6C6F6779204D656469636174696F6E205574696C697A6174696F6E200A0A4A616E756172792032342C20323031390A436C696E6963616C2050726573656E746174696F6E7320616E6420426F6172642044697363757373696F6E3A0A09416E74692D4E656F706C6173746963204167656E74733B206164646974696F6E206F6620637269746572696120666F7220616C6C206F72616C20616E74692D6E656F706C6173746963206167656E747320200A09496E68616C65642053686F72742D416374696E6720426574612041676F6E697374733B207175616E74697479206C696D6974206F662074776F20756E69747320706572206D6F6E746820616464656420200A09436F6D706F756E64204D656469636174696F6E733B206372697465726961207265766973656420746F20696E636C75646520616C6C206F757470617469656E7420636F6D706F756E646564206D656469636174696F6E730A095361637562697472696C2F56616C73617274616E2028456E74726573746F293B2063726974657269612072656D6F7665640A0943616E6E61626964696F6C202845706964696F6C6578293B206164646974696F6E206F66206E657720637269746572696120200A094D656469636174696F6E7320666F72207468652054726561746D656E74206F662050756C6D6F6E61727920417274657269616C20487970657274656E73696F6E3B20616464656420646961676E6F73697320726571756972656D656E7420200A426F617264205265706F7274733A0A094869676820446F6C6C617220436C61696D732028436C61696D73204F766572202431302C303030290A09546F70204F70696F6964205574696C697A6174696F6E206279205072657363726962657220616E64204D656D6265720A09416E746962696F746963205574696C697A6174696F6E0A0A417072696C2032352C20323031390A436C696E6963616C2050726573656E746174696F6E7320616E6420426F6172642044697363757373696F6E3A0A095375627374616E6365204162757365204167656E74733B206164646974696F6E206F6620637269746572696120666F72204C7563656D797261200A094144442F414448442054726561746D656E74733B2072657669736564206578697374696E67206372697465726961200A09416E64726F67656E2F546573746F737465726F6E65205265706C6163656D656E74204167656E74733B206372697465726961207265766973656420746F20696E636C75646520696E6A65637461626C6520746573746F737465726F6E65200A0946656E74616E796C3B2072657669736564206578697374696E672063726974657269610A426F617264205265706F7274733A0A09546F70204F70696F6964205574696C697A6174696F6E206279205072657363726962657220616E64204D656D6265720A09546F7020436C61696D7320666F72204D656D6265727320556E646572203138207965617273206F66206167650A0A4A756C792032352C20323031390A436C696E6963616C2050726573656E746174696F6E7320616E6420426F6172642044697363757373696F6E3A0A0947726F77746820486F726D6F6E65733B207265766973656420637269746572696120200A0945736B6574616D696E652028537072617661746F293B206164646974696F6E206F66206E6577206372697465726961200A094167656E747320666F72207468652054726561746D656E74206F66204368726F6E6963204964696F70617468696320436F6E737469706174696F6E2028434943293B206164646564206164646974696F6E616C206167656E747320616E642075706461746564207468652063726974657269610A095472697074616E733B207265766973656420746865206578697374696E67206372697465726961200A426F617264205265706F7274733A0A09546F70204F70696F6964205574696C697A6174696F6E206279205072657363726962657220616E64204D656D6265720A094F70696F696420557365204469736F7264657220616E64204F70696F6964205573650A095370656369616C74792044727567205574696C697A6174696F6E0A0A>
>>
endobj
137 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [646 0 R 647 0 R]
/T (S04Q00002)
/TU (Does your state have an approved CMS Medication Therapy Management Program?)
/V /No
>>
endobj
138 0 obj
<<
/AP <<
/N 648 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 649 0 R
/Rect [182.912 461.898 542.359 535.067]
/Subtype /Widget
/T (S04Q2A01A)
/TU (If "Yes," please provide a brief summary of your findings.)
/Type /Annot
>>
endobj
139 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [650 0 R 651 0 R]
/T (S04Q02A01)
/TU (Have you performed an analysis of the program's effectiveness?)
>>
endobj
140 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [652 0 R 653 0 R]
/T (S04Q02A02)
/TU (Is your DUR Board involved with this program?)
>>
endobj
141 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [654 0 R 655 0 R]
/T (S04Q0002B)
/TU (Are you planning to develop and implement a program?)
/V /Yes
>>
endobj
142 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [656 0 R 657 0 R]
/T (S05Q00001)
/TU (ProDUR?)
/V /Yes
>>
endobj
143 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [658 0 R 659 0 R]
/T (S05Q0001A)
/TU (Do you have a plan to include this information in your DUR criteria in the future?)
>>
endobj
144 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [660 0 R 661 0 R]
/T (S05Q00002)
/TU (RetroDUR?)
/V /Yes
>>
endobj
145 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [662 0 R 663 0 R]
/T (S05Q0002A)
/TU (Do you have a plan to include this information in your DUR criteria in the future?)
>>
endobj
146 0 obj
<<
/AP <<
/N 664 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 665 0 R
/Rect [124.69 519.178 545.178 640.705]
/Subtype /Widget
/T (S06Q00001)
/TU (Summary 4 - Generic Drug Substitution Policies)
/Type /Annot
/V (NRS 639.2583 requires that if a practitioner has prescribed a drug by brand name and the practitioner has not indicated that a substitution is prohibited, the pharmacist who fills or refills the prescription shall dispense, in substitution, another drug which is available to him or her if the other drug is a\) less expensive than the drug prescribed by brand name; b\) is biologically equivalent to the drug prescribed by brand name; c\) has the same active ingredient or ingredients of the same strength, quantity and form of dosage as the drug prescribed by brand name; and d\) is of the same generic type as the drug prescribed by brand name. If the pharmacist has available to him or her more than one drug that may be substituted for the drug prescribed by brand name, the pharmacist shall dispense, in substitution, the least expensive of the drugs that are available to him or her for substitution. Before a pharmacist dispenses a drug in substitution for a drug prescribed by brand name, the pharmacist shall: a\) advise the person who presents the prescription that the pharmacist intends to dispense a drug in substitution; and b\) advise the person that he or she may refuse to accept the drug that the pharmacist intends to dispense in substitution, unless the pharmacist is being paid for the drug by a governmental agency. If a person refuses to accept the drug that the pharmacist intends to dispense in substitution, the pharmacist shall dispense the drug prescribed by brand name, unless the pharmacist is being paid for the drug by a governmental agency, in which case the pharmacist shall dispense the drug in substitution.)
>>
endobj
147 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [666 0 R 667 0 R]
/T (S06Q00002)
/TU (In addition to the requirement that the prescriber write in his own handwriting "Brand Medically Necessary" for a brand name drug to be dispensed in lieu of the generic equivalent, does your state have a more restrictive requirement?)
/V /Yes
>>
endobj
148 0 obj
<<
/AP <<
/D <<
/Off 668 0 R
/On 669 0 R
>>
/N <<
/On 670 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 665 0 R
/Rect [149.36 355.92 162.68 366.36]
/Subtype /Widget
/T (S06Q0002A_20032)
/TU (If "Yes," check all that apply. Require that a MedWatch Form be submitted)
/Type /Annot
/V /On
>>
endobj
149 0 obj
<<
/AP <<
/D <<
/Off 671 0 R
/On 672 0 R
>>
/N <<
/On 673 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 665 0 R
/Rect [149.36 334.92 162.68 345.36]
/Subtype /Widget
/T (S06Q0002A_20033)
/TU (Refer to Lock-In Program)
/Type /Annot
/V /On
>>
endobj
150 0 obj
<<
/AP <<
/D <<
/Off 674 0 R
/On 675 0 R
>>
/N <<
/On 676 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 665 0 R
/Rect [149.04 314.92 162.36 325.36]
/Subtype /Widget
/T (S06Q0002A_20034)
/TU (Refer to Program Integrity Unit)
/Type /Annot
/V /On
>>
endobj
151 0 obj
<<
/AP <<
/D <<
/Off 677 0 R
/On 678 0 R
>>
/N <<
/On 679 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 665 0 R
/Rect [149.04 293.56 162.36 304.0]
/Subtype /Widget
/T (S06Q0002A_20036)
/TU (Other)
/Type /Annot
/V /Off
>>
endobj
152 0 obj
<<
/AP <<
/N 680 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 665 0 R
/Rect [170.582 193.259 540.991 266.428]
/Subtype /Widget
/T (S06Q02A01)
/TU (Total Number of Claims for Single Source \(S\) Drugs)
/Type /Annot
>>
endobj
153 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 681 0 R
/Q 2
/Rect [232.56 143.76 328.68 165.6]
/Subtype /Widget
/T (S06T2R1C1)
/TU (Total Number of Claims for Single Source \(S\) Drugs)
/Type /Annot
/V (387,312)
/AP 682 0 R
>>
endobj
154 0 obj
<<
/AA <<
/V 683 0 R
>>
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 681 0 R
/Q 2
/Rect [335.593 143.76 433.963 165.6]
/Subtype /Widget
/T (S06T2R1C2)
/TU (Total Number of Claims for Non-Innovator \(N\) Drugs)
/Type /Annot
/V (2,225,496)
/AP 684 0 R
>>
endobj
155 0 obj
<<
/AA <<
/V 685 0 R
>>
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 681 0 R
/Q 2
/Rect [437.348 143.76 553.718 165.6]
/Subtype /Widget
/T (S06T2R1C3)
/TU (Total Number of Claims for Innovator Multi-Source \(I\) Drugs)
/Type /Annot
/V (72,068)
/AP 686 0 R
>>
endobj
156 0 obj
<<
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 681 0 R
/Q 2
/Rect [232.597 110.111 328.717 131.951]
/Subtype /Widget
/T (S06T2R2C1)
/TU (Total Reimbursement Amount Less Co-Pay for Single Source \(S\) Drugs)
/Type /Annot
/V (288,072,796.23)
/AP 687 0 R
>>
endobj
157 0 obj
<<
/AA <<
/V 688 0 R
>>
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 681 0 R
/Q 2
/Rect [334.58 110.111 432.95 131.951]
/Subtype /Widget
/T (S06T2R2C2)
/TU (Total Reimbursement Amount Less Co-Pay for Non-Innovator \(N\) Drugs)
/Type /Annot
/V (44,337,119.66)
/AP 689 0 R
>>
endobj
158 0 obj
<<
/AA <<
/V 690 0 R
>>
/DA (/HeBo 8 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 681 0 R
/Q 2
/Rect [437.348 110.111 553.718 131.951]
/Subtype /Widget
/T (S06T2R2C3)
/TU (Total Reimbursement Amount Less Co-Pay for Innovator Multi-Source \(I\) Drugs)
/Type /Annot
/V (17,397,802.36)
/AP 691 0 R
>>
endobj
159 0 obj
<<
/AA <<
/V 692 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 693 0 R
/Q 2
/Rect [289.539 650.697 396.458 672.537]
/Subtype /Widget
/T (S06Q0003A)
/TU (Number of Generic Claims)
/Type /Annot
/V (2,225,496)
/AP 694 0 R
>>
endobj
160 0 obj
<<
/AA <<
/V 695 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 693 0 R
/Q 2
/Rect [288.939 627.256 397.058 649.097]
/Subtype /Widget
/T (S06Q0003B)
/TU (Total Number of Claims)
/Type /Annot
/V (2,684,876)
/AP 696 0 R
>>
endobj
161 0 obj
<<
/AA <<
/V 697 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 693 0 R
/Q 2
/Rect [288.639 602.53 397.358 624.37]
/Subtype /Widget
/T (S06Q0003C)
/TU (Generic Utilization Percentage)
/Type /Annot
/V (82.89)
/AP 698 0 R
>>
endobj
162 0 obj
<<
/AA <<
/V 699 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 693 0 R
/Q 2
/Rect [295.826 511.497 395.545 533.337]
/Subtype /Widget
/T (S06Q0004A)
/TU (Generic Dollars)
/Type /Annot
/V (44,337,119.66)
/AP 700 0 R
>>
endobj
163 0 obj
<<
/AA <<
/V 701 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 693 0 R
/Q 2
/Rect [295.526 484.057 395.845 505.897]
/Subtype /Widget
/T (S06Q0004B)
/TU (Total Dollars)
/Type /Annot
/V (349,807,718.25)
/AP 702 0 R
>>
endobj
164 0 obj
<<
/AA <<
/V 703 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 693 0 R
/Q 2
/Rect [295.451 461.33 395.919 483.17]
/Subtype /Widget
/T (S06Q0004C)
/TU (Generic Expenditure Percentage)
/Type /Annot
/V (12.67)
/AP 704 0 R
>>
endobj
165 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [705 0 R 706 0 R]
/T (S07Q00001)
/TU (Did your state conduct a DUR program evaluation of the estimated cost savings/cost avoidance?)
/V /Yes
>>
endobj
166 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [707 0 R 708 0 R 709 0 R]
/T (S07Q01A02)
/TU (Institution Type)
/V /Company
>>
endobj
167 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 1
/MK <<
>>
/MaxLen 300000
/P 710 0 R
/Rect [143.332 410.235 541.598 436.515]
/Subtype /Widget
/T (S07Q01A01)
/TU (If "Yes," identify, by name and type, the institution that conducted the program evaluation. Institution Name)
/Type /Annot
/V (OptumRx)
/AP 711 0 R
>>
endobj
168 0 obj
<<
/AA <<
/V 712 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 710 0 R
/Q 2
/Rect [396.518 289.867 532.969 311.707]
/Subtype /Widget
/T (S07T2R1C1)
/TU (ProDUR Total Estimated Avoided Costs)
/Type /Annot
/V (281,604,516.91)
/AP 713 0 R
>>
endobj
169 0 obj
<<
/AA <<
/V 714 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 710 0 R
/Q 2
/Rect [396.255 259.615 532.969 281.454]
/Subtype /Widget
/T (S07T2R2C1)
/TU (RetroDUR Total Estimated Avoided Costs)
/Type /Annot
/V (3,010.45)
/AP 715 0 R
>>
endobj
170 0 obj
<<
/AA <<
/V 716 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 710 0 R
/Q 2
/Rect [396.124 229.388 532.969 251.229]
/Subtype /Widget
/T (S07T2R3C1)
/TU (Other Cost Avoidance)
/Type /Annot
/V (0)
/AP 717 0 R
>>
endobj
171 0 obj
<<
/AA <<
/V 718 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 710 0 R
/Q 2
/Rect [396.125 198.919 532.969 220.76]
/Subtype /Widget
/T (S07T2R4C1)
/TU (Grand Total Estimated Avoided Costs)
/Type /Annot
/V (281,607,527.36)
/AP 719 0 R
>>
endobj
172 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 710 0 R
/Q 2
/Rect [288.105 92.7724 396.825 114.613]
/Subtype /Widget
/T (S07Q0003A)
/TU (Estimated Percent Impact)
/Type /Annot
/V (80.5)
/AP 720 0 R
>>
endobj
173 0 obj
<<
/AP <<
/N 721 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 722 0 R
/Rect [125.464 529.673 545.952 636.93]
/Subtype /Widget
/T (S07H0004B)
/TU (Summary 5 - Cost Savings/Cost Avoidance Methodology)
/Type /Annot
/V <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>
>>
endobj
174 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [723 0 R 724 0 R]
/T (S08QA1001)
/TU (Does the state have Attachment 5 described above to upload?)
/V /Yes
>>
endobj
175 0 obj
<<
/AP <<
/D <<
/Off 725 0 R
/On 726 0 R
>>
/N <<
/On 727 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 722 0 R
/Rect [148.339 309.011 161.659 319.451]
/Subtype /Widget
/T (S08QA101A_20582)
/TU (If "Yes," what actions does this process initiate? Check all that apply: Deny claims and require prior authorization)
/Type /Annot
/V /Off
>>
endobj
176 0 obj
<<
/AP <<
/D <<
/Off 728 0 R
/On 729 0 R
>>
/N <<
/On 730 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 722 0 R
/Rect [148.32 288.051 161.64 298.491]
/Subtype /Widget
/T (S08QA101A_20583)
/TU (Refer to Lock-In Program)
/Type /Annot
/V /On
>>
endobj
177 0 obj
<<
/AP <<
/D <<
/Off 731 0 R
/On 732 0 R
>>
/N <<
/On 733 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 722 0 R
/Rect [148.32 266.147 161.64 277.5]
/Subtype /Widget
/T (S08QA101A_20584)
/TU (Refer to Program Integrity Unit/State Utilization Review \(SURS unit\))
/Type /Annot
/V /On
>>
endobj
178 0 obj
<<
/AP <<
/D <<
/Off 734 0 R
/On 735 0 R
>>
/N <<
/On 736 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 722 0 R
/Rect [148.32 228.897 161.64 239.337]
/Subtype /Widget
/T (S08QA101A_20585)
/TU (Refer to Office of Inspector General)
/Type /Annot
/V /Off
>>
endobj
179 0 obj
<<
/AP <<
/D <<
/Off 737 0 R
/On 738 0 R
>>
/N <<
/On 739 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 722 0 R
/Rect [148.122 208.326 161.442 218.766]
/Subtype /Widget
/T (S08QA101A_20586)
/TU (Other)
/Type /Annot
/V /Off
>>
endobj
180 0 obj
<<
/AP <<
/N 740 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 722 0 R
/Rect [174.795 112.743 545.204 185.912]
/Subtype /Widget
/T (S08QA11A1)
/TU (Other, please explain)
/Type /Annot
>>
endobj
181 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [741 0 R 742 0 R]
/T (S08QA1002)
/TU (Do you have a Lock-In program for beneficiaries with potential misuse or abuse of controlled substances?)
/V /Yes
>>
endobj
182 0 obj
<<
/AP <<
/D <<
/Off 743 0 R
/On 744 0 R
>>
/N <<
/On 745 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 746 0 R
/Rect [161.294 550.993 174.974 561.073]
/Subtype /Widget
/T (S08QA102A_20045)
/TU (What criteria does your state use to identify candidates for Lock-In? Check all that apply: Number of controlled substances \(CS\))
/Type /Annot
/V /On
>>
endobj
183 0 obj
<<
/AP <<
/D <<
/Off 747 0 R
/On 748 0 R
>>
/N <<
/On 749 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 746 0 R
/Rect [161.486 529.618 174.806 540.058]
/Subtype /Widget
/T (S08QA102A_20046)
/TU (Different prescribers of CS)
/Type /Annot
/V /On
>>
endobj
184 0 obj
<<
/AP <<
/D <<
/Off 750 0 R
/On 751 0 R
>>
/N <<
/On 752 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 746 0 R
/Rect [161.486 509.368 174.806 519.808]
/Subtype /Widget
/T (S08QA102A_20047)
/TU (Multiple pharmacies)
/Type /Annot
/V /On
>>
endobj
185 0 obj
<<
/AP <<
/D <<
/Off 753 0 R
/On 754 0 R
>>
/N <<
/On 755 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 746 0 R
/Rect [161.486 487.868 174.806 498.308]
/Subtype /Widget
/T (S08QA102A_20048)
/TU (Number days' supply of CS)
/Type /Annot
/V /Off
>>
endobj
186 0 obj
<<
/AP <<
/D <<
/Off 756 0 R
/On 757 0 R
>>
/N <<
/On 758 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 746 0 R
/Rect [161.486 467.368 174.806 477.808]
/Subtype /Widget
/T (S08QA102A_20049)
/TU (Exclusivity of short acting opioids)
/Type /Annot
/V /Off
>>
endobj
187 0 obj
<<
/AP <<
/D <<
/Off 759 0 R
/On 760 0 R
>>
/N <<
/On 761 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 746 0 R
/Rect [161.486 447.118 174.806 457.558]
/Subtype /Widget
/T (S08QA102A_20050)
/TU (Multiple ER visits)
/Type /Annot
/V /On
>>
endobj
188 0 obj
<<
/AP <<
/D <<
/Off 762 0 R
/On 763 0 R
>>
/N <<
/On 764 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 746 0 R
/Rect [161.486 425.618 174.806 436.058]
/Subtype /Widget
/T (S08QA102A_20051)
/TU (PDMP data)
/Type /Annot
/V /On
>>
endobj
189 0 obj
<<
/AP <<
/D <<
/Off 765 0 R
/On 766 0 R
>>
/N <<
/On 767 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 746 0 R
/Rect [161.486 405.118 174.806 415.558]
/Subtype /Widget
/T (S08QA102A_20052)
/TU (Other)
/Type /Annot
/V /On
>>
endobj
190 0 obj
<<
/AP <<
/N 768 0 R
>>
/DA (/HeBo 9 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 746 0 R
/Rect [183.716 309.536 541.805 382.705]
/Subtype /Widget
/T (S08QA12A1)
/TU (If "Other," please explain.)
/Type /Annot
/V (If the recipient has been diagnosed with a drug dependency related condition or if the dispensed quantity per prescription of controlled substances appears excessive by the clinical review team; or the recipient has other noted drug seeking behaviors. )
>>
endobj
191 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [769 0 R 770 0 R]
/T (S08QA12B1)
/TU (Do you have the capability to restrict the beneficiary to: i\) prescriber only)
/V /Yes
>>
endobj
192 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [771 0 R 772 0 R]
/T (S08QA12B2)
/TU (ii\) pharmacy only)
/V /Yes
>>
endobj
193 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [773 0 R 774 0 R]
/T (S08QA12B3)
/TU (iii\) prescriber and pharmacy only)
/V /Yes
>>
endobj
194 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [775 0 R 776 0 R 777 0 R 778 0 R 779 0 R 780 0 R]
/T (S08QA102C)
/TU (What is the usual Lock-in time period?)
/V /As#20determined#20by#20the#20state#20on#20a#20case#20by#20case#20basis
>>
endobj
195 0 obj
<<
/AP <<
/N 781 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 782 0 R
/Rect [188.695 197.271 544.983 270.44]
/Subtype /Widget
/T (S08QA12C1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
196 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 300000
/P 782 0 R
/Q 2
/Rect [161.947 126.517 252.38 148.357]
/Subtype /Widget
/T (S08QA102D)
/TU (On the average, what percentage of the FFS population is in Lock-In status annually?)
/Type /Annot
/V (0.44)
/AP 783 0 R
>>
endobj
197 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 300000
/P 784 0 R
/Rect [167.804 667.971 279.578 689.811]
/Subtype /Widget
/T (S08QA102E)
/TU (Please provide an estimate of the savings attributed to the Lock-In program for the fiscal year under review as part of Attachment 5.)
/Type /Annot
/V (1,506,335)
/AP 785 0 R
>>
endobj
198 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [786 0 R 787 0 R]
/T (S08QA1003)
/TU (o you have a documented process in place that identifies possible fraud or abuse of controlled drugs by prescribers?)
/V /No
>>
endobj
199 0 obj
<<
/AP <<
/D <<
/Off 788 0 R
/On 789 0 R
>>
/N <<
/On 790 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 784 0 R
/Rect [165.417 514.452 178.737 524.892]
/Subtype /Widget
/T (S08QA103A_20057)
/TU (Deny claims written by this prescriber)
/Type /Annot
/V /Off
>>
endobj
200 0 obj
<<
/AP <<
/D <<
/Off 791 0 R
/On 792 0 R
>>
/N <<
/On 793 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 784 0 R
/Rect [165.417 500.452 178.737 510.892]
/Subtype /Widget
/T (S08QA103A_20058)
/TU (Refer to Program Integrity Unit)
/Type /Annot
/V /Off
>>
endobj
201 0 obj
<<
/AP <<
/D <<
/Off 794 0 R
/On 795 0 R
>>
/N <<
/On 796 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 784 0 R
/Rect [165.417 485.452 178.737 495.892]
/Subtype /Widget
/T (S08QA103A_20059)
/TU (Refer to the appropriate Medical Board)
/Type /Annot
/V /Off
>>
endobj
202 0 obj
<<
/AP <<
/D <<
/Off 797 0 R
/On 798 0 R
>>
/N <<
/On 799 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 784 0 R
/Rect [165.417 470.202 178.737 480.642]
/Subtype /Widget
/T (S08QA103A_20060)
/TU (Other)
/Type /Annot
/V /Off
>>
endobj
203 0 obj
<<
/AP <<
/N 800 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 784 0 R
/Rect [186.727 375.265 558.545 448.435]
/Subtype /Widget
/T (S08QA13A1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
204 0 obj
<<
/AP <<
/N 801 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 784 0 R
/Rect [165.365 229.34 541.547 302.51]
/Subtype /Widget
/T (S08QA103B)
/TU (If "No," please explain.)
/Type /Annot
/V (Currently, the program does not include regular reviews to identify prescribers for possible fraud or abuse of controlled substances. Reporting is provided to the DUR Board and regular reports are reviewed for other initiatives; any anomalies are reported to the SUR unit for investigation.)
>>
endobj
205 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [802 0 R 803 0 R]
/T (S08QA1004)
/TU (Do you have a documented process in place that identifies potential fraud or abuse of controlled drugs by pharmacy providers?)
/V /No
>>
endobj
206 0 obj
<<
/AP <<
/D <<
/Off 804 0 R
/On 805 0 R
>>
/N <<
/On 806 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 807 0 R
/Rect [165.124 609.951 177.944 620.391]
/Subtype /Widget
/T (S08QA104A_20061)
/TU (Deny claim)
/Type /Annot
/V /Off
>>
endobj
207 0 obj
<<
/AP <<
/D <<
/Off 808 0 R
/On 809 0 R
>>
/N <<
/On 810 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 807 0 R
/Rect [164.211 594.951 178.444 605.391]
/Subtype /Widget
/T (S08QA104A_20062)
/TU (Refer to Program Integrity Unit)
/Type /Annot
/V /Off
>>
endobj
208 0 obj
<<
/AP <<
/D <<
/Off 811 0 R
/On 812 0 R
>>
/N <<
/On 813 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 807 0 R
/Rect [165.124 579.951 178.444 590.391]
/Subtype /Widget
/T (S08QA104A_20063)
/TU (Refer to Board of Pharmacy)
/Type /Annot
/V /Off
>>
endobj
209 0 obj
<<
/AP <<
/D <<
/Off 814 0 R
/On 815 0 R
>>
/N <<
/On 816 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 807 0 R
/Rect [165.124 564.319 178.444 574.759]
/Subtype /Widget
/T (S08QA104A_20064)
/TU (Other)
/Type /Annot
/V /Off
>>
endobj
210 0 obj
<<
/AP <<
/N 817 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 807 0 R
/Rect [170.673 468.234 542.491 541.403]
/Subtype /Widget
/T (S08QA14A1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
211 0 obj
<<
/AP <<
/N 818 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 807 0 R
/Rect [164.909 332.416 536.727 405.585]
/Subtype /Widget
/T (S08QA104B)
/TU (If "No," please explain.)
/Type /Annot
/V (Currently, the program does not include regular reviews to identify prescribers for possible fraud or abuse of controlled substances. Reporting is provided to the DUR Board and regular reports are reviewed for other initiatives; any anomalies are reported to the SUR unit for investigation.)
>>
endobj
212 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [819 0 R 820 0 R]
/T (S08QA1005)
/TU (Do you have a documented process in place that identifies and/or prevents potential fraud or abuse of non-controlled drugs by beneficiaries?)
/V /No
>>
endobj
213 0 obj
<<
/AP <<
/N 821 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 822 0 R
/Rect [148.077 554.433 540.906 627.602]
/Subtype /Widget
/T (S08QA105A)
/TU (If "Yes," please explain your program for fraud, waste, or abuse of non-controlled substances.)
/Type /Annot
>>
endobj
214 0 obj
<<
/AP <<
/N 823 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 822 0 R
/Rect [147.549 438.034 540.378 511.203]
/Subtype /Widget
/T (S08QA105B)
/TU (If "No," please explain.)
/Type /Annot
/V (Currently, the program does not include regular reviews to identify pharmacy providers for possible fraud or abuse of controlled substances. Reporting is provided to the DUR Board and regular reports are reviewed for other initiatives; any anomalies are reported to the SUR unit for investigation.)
>>
endobj
215 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [824 0 R 825 0 R]
/T (S08QA2001)
/TU (Does your state have a Prescription Drug Monitoring Program \(PDMP\)?)
/V /Yes
>>
endobj
216 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [826 0 R 827 0 R 828 0 R]
/T (S08QA201A)
/TU (Does your agency have the ability to query the state's PDMP database?)
/V /Yes#2C#20we#20have#20access#20to#20the#20database
>>
endobj
217 0 obj
<<
/AP <<
/N 829 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 830 0 R
/Rect [179.571 587.688 540.428 660.857]
/Subtype /Widget
/T (S08QA21A1)
/TU (Please explain how the state applies this information to control fraud and abuse.)
/Type /Annot
/V (A query may be used during a Lock-In evaluation of a recipient. )
>>
endobj
218 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [831 0 R 832 0 R]
/T (S08QA21A2)
/TU (Do you also have access to border states' PDMP information?)
/V /Yes
>>
endobj
219 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [833 0 R 834 0 R]
/T (S08QA21A3)
/TU (Do you also have PDMP data \(i.e. outside of MMIS, such as a controlled substance that was paid for by using cash\) integrated into your POS edits?)
/V /No
>>
endobj
220 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [835 0 R 836 0 R]
/T (S08QA201B)
/TU (Do you require prescribers \(in your provider agreement with the agency\) to access the PDMP patient history before prescribing controlled substances?)
/V /No
>>
endobj
221 0 obj
<<
/AP <<
/N 837 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 830 0 R
/Rect [182.699 110.58 543.556 183.75]
/Subtype /Widget
/T (S08QA21C1)
/TU (Please explain the barriers \(i.e. lag time in prescription data being submitted, prescribers not accessing, pharmacists unable to view prescription history before filling script\).)
/Type /Annot
/V (Only one State employee is allowed access and none of the Managed Care Organizations have access. The Nevada PDMP only includes data on controlled substances, not all drugs. There are inconsistencies and inaccuracies in the way that data is entered by the pharmacist filling the prescription. For example, a pharmacist enters in coupon as payment method, then when contacted and asked about the coupon, the pharmacy staff has stated that it may have been entered incorrectly. )
>>
endobj
222 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [838 0 R 839 0 R]
/T (S08QA201C)
/TU (Are there barriers that hinder the agency from fully accessing the PDMP that prevent the program from being utilized the way it was intended to be to curb abuse?)
/V /Yes
>>
endobj
223 0 obj
<<
/AP <<
/N 840 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 841 0 R
/Rect [166.217 555.581 561.574 628.75]
/Subtype /Widget
/T (S08QA202A)
/TU (If "Yes," please explain.)
/Type /Annot
>>
endobj
224 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [842 0 R 843 0 R]
/T (S08QA2002)
/TU (Have you had any changes to your state's Prescription Drug Monitoring Program during this reporting period that have improved the agency's ability to access PDMP data?)
/V /No
>>
endobj
225 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [844 0 R 845 0 R]
/T (S08QA3001)
/TU (Does your program obtain the DEA Active Controlled Substance Registrant's File in order to identify prescribers not authorized to prescribe controlled drugs?)
/V /No
>>
endobj
226 0 obj
<<
/FT /Btn
/Ff 49153
/Kids [846 0 R 847 0 R]
/T (S08QA301A)
/TU (Do you apply this DEA file to your ProDUR POS edits to prevent unauthorized prescribing?)
>>
endobj
227 0 obj
<<
/AP <<
/N 848 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 841 0 R
/Rect [170.388 141.596 540.789 214.765]
/Subtype /Widget
/T (S08QA31A1)
/TU (If "Yes," please explain how the information is applied.)
/Type /Annot
>>
endobj
228 0 obj
<<
/FT /Btn
/Ff 49153
/Kids [849 0 R 850 0 R]
/T (S08QA31A2)
/TU (Do you plan to obtain the DEA Active Controlled Substance Registrant's file and apply it to your POS edits?)
>>
endobj
229 0 obj
<<
/AP <<
/N 851 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 852 0 R
/Rect [201.49 545.961 544.4 619.13]
/Subtype /Widget
/T (S08QA31A3)
/TU (If "Yes," please explain how the information is applied.)
/Type /Annot
>>
endobj
230 0 obj
<<
/AP <<
/N 853 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 852 0 R
/Rect [181.527 400.217 544.21 473.386]
/Subtype /Widget
/T (S08QA31B1)
/TU (If "Yes," please explain how it is applied.)
/Type /Annot
>>
endobj
231 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [854 0 R 855 0 R]
/T (S08QA301B)
/TU (Do you apply this DEA file to your RetroDUR reviews?)
>>
endobj
232 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [856 0 R 857 0 R]
/T (S08QA3002)
/TU (Do you have a measure \(i.e. prior authorization, quantity limits\) in place to either monitor or manage the prescribing of methadone for pain management?)
/V /No
>>
endobj
233 0 obj
<<
/AP <<
/N 858 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 852 0 R
/Rect [147.923 159.118 546.183 232.287]
/Subtype /Widget
/T (S08QA302A)
/TU (If "No," please explain why you do not have measures in place to either manage or monitor the prescribing of methadone for pain management.)
/Type /Annot
/V (Methadone is non-preferred in the opioid drug class on the Nevada PDL. )
>>
endobj
234 0 obj
<<
/AP <<
/N 859 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 860 0 R
/Rect [124.965 495.893 540.475 569.062]
/Subtype /Widget
/T (S08QA401S)
/TU (Please explain answer above)
/Type /Annot
/V (All opioids are limited to 60 morphine equivalents, a max of seven-day supply and a maximum of 13 fills per rolling 12 months for adults. For children under 18 years of age, the day supply is limited to three. )
>>
endobj
235 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [861 0 R 862 0 R 863 0 R]
/T (S08QA4001)
/TU (Do you currently have a POS edit in place to limit the quantity dispensed of an initial opioid prescription?)
/V /Yes#2C#20for#20all#20opioids
>>
endobj
236 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [864 0 R 865 0 R]
/T (S08QA401A)
/TU (Do you apply this DEA file to your RetroDUR reviews?)
/V /No
>>
endobj
237 0 obj
<<
/AP <<
/N 866 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 860 0 R
/Rect [184.154 299.034 545.01 372.203]
/Subtype /Widget
/T (S08QA41A1)
/TU (If "Yes," please explain.)
/Type /Annot
>>
endobj
238 0 obj
<<
/DA (/HeBo 12 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 300000
/P 860 0 R
/Q 1
/Rect [161.79 188.88 200.828 210.72]
/Subtype /Widget
/T (S08QA401B)
/TU (What is the maximum number of days allowed for an initial opioid prescription?)
/Type /Annot
/V (7)
/AP 867 0 R
>>
endobj
239 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [868 0 R 869 0 R 870 0 R]
/T (S08QA401C)
/TU (Does this day limit apply to all opioid prescriptions?)
/V /Yes#2C#20for#20all#20opioids
>>
endobj
240 0 obj
<<
/AP <<
/N 871 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 872 0 R
/Rect [183.209 627.288 542.026 700.457]
/Subtype /Widget
/T (S08QA41C1)
/TU (If "No," please explain.)
/Type /Annot
>>
endobj
241 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [873 0 R 874 0 R]
/T (S08QA4002)
/TU (Do you have a measure \(i.e. prior authorization, quantity limits\) in place to either monitor or manage the prescribing of methadone for pain management?)
/V /Yes
>>
endobj
242 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [875 0 R 876 0 R 877 0 R 878 0 R]
/T (S08QA402A)
/TU (What is your maximum days supply per prescription limitation?)
/V /Other
>>
endobj
243 0 obj
<<
/AP <<
/N 879 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 872 0 R
/Rect [187.607 328.488 562.502 401.657]
/Subtype /Widget
/T (S08QA42A1)
/TU (If "Other," please explain.)
/Type /Annot
/V (All fills are limited to seven-day supply without obtaining prior authorization. )
>>
endobj
244 0 obj
<<
/AP <<
/N 880 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 872 0 R
/Rect [165.37 192.67 540.266 265.839]
/Subtype /Widget
/T (S08QA402B)
/TU (If "No," please explain.)
/Type /Annot
>>
endobj
245 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [881 0 R 882 0 R]
/T (S08QA4003)
/TU (Do you currently have POS edits in place to limit the quantity dispensed of long-acting opioids?)
/V /Yes
>>
endobj
246 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [883 0 R 884 0 R 885 0 R 886 0 R]
/T (S08QA403A)
/TU (If "Yes," what is your maximum days supply per prescription limitation?)
/V /Other
>>
endobj
247 0 obj
<<
/AP <<
/N 887 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 888 0 R
/Rect [182.861 427.325 557.756 500.494]
/Subtype /Widget
/T (S08QA43A1)
/TU (If "Other," please explain.)
/Type /Annot
/V (Recipients can get up-to 34-day supply with an approved prior authorization \(PA\). A recipient limited to a seven-day supply without a PA. )
>>
endobj
248 0 obj
<<
/AP <<
/N 889 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 888 0 R
/Rect [178.116 312.125 553.011 385.294]
/Subtype /Widget
/T (S08QA403B)
/TU (If "No," please explain.)
/Type /Annot
>>
endobj
249 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [890 0 R 891 0 R]
/T (S08QA4004)
/TU (o you have a documented process in place that identifies possible fraud or abuse of controlled drugs by prescribers?)
/V /Yes
>>
endobj
250 0 obj
<<
/AP <<
/D <<
/Off 892 0 R
/On 893 0 R
>>
/N <<
/On 894 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [166.668 588.215 179.988 598.655]
/Subtype /Widget
/T (S08QA404A_20604)
/TU (Pharmacist override)
/Type /Annot
/V /Off
>>
endobj
251 0 obj
<<
/AP <<
/D <<
/Off 896 0 R
/On 897 0 R
>>
/N <<
/On 898 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [166.32 570.215 179.64 580.655]
/Subtype /Widget
/T (S08QA404A_20606)
/TU (Deny claim and require PA)
/Type /Annot
/V /On
>>
endobj
252 0 obj
<<
/AP <<
/D <<
/Off 899 0 R
/On 900 0 R
>>
/N <<
/On 901 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [165.993 552.433 179.313 562.873]
/Subtype /Widget
/T (S08QA404A_20607)
/TU (Intervention letters)
/Type /Annot
/V /Off
>>
endobj
253 0 obj
<<
/AP <<
/D <<
/Off 902 0 R
/On 903 0 R
>>
/N <<
/On 904 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [165.993 535.183 179.313 545.623]
/Subtype /Widget
/T (S08QA404A_20608)
/TU (Morphine Milligram Equivalent \(MME\) daily dose program)
/Type /Annot
/V /On
>>
endobj
254 0 obj
<<
/AP <<
/D <<
/Off 905 0 R
/On 906 0 R
>>
/N <<
/On 907 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [165.993 517.183 179.313 527.623]
/Subtype /Widget
/T (S08QA404A_20609)
/TU (Step therapy or clinical criteria)
/Type /Annot
/V /Off
>>
endobj
255 0 obj
<<
/AP <<
/D <<
/Off 908 0 R
/On 909 0 R
>>
/N <<
/On 910 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [165.993 499.183 179.313 509.623]
/Subtype /Widget
/T (S08QA404A_20610)
/TU (Requirement that patient has a pain management contract or Patient-Provider agreement)
/Type /Annot
/V /On
>>
endobj
256 0 obj
<<
/AP <<
/D <<
/Off 911 0 R
/On 912 0 R
>>
/N <<
/On 913 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [165.993 466.183 179.313 476.623]
/Subtype /Widget
/T (S08QA404A_20611)
/TU (Requirement that prescriber has an opioid treatment plan for patients)
/Type /Annot
/V /Off
>>
endobj
257 0 obj
<<
/AP <<
/D <<
/Off 914 0 R
/On 915 0 R
>>
/N <<
/On 916 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [165.993 447.933 179.313 458.373]
/Subtype /Widget
/T (S08QA404A_20612)
/TU (Require documentation of urine drug screening results)
/Type /Annot
/V /Off
>>
endobj
258 0 obj
<<
/AP <<
/D <<
/Off 917 0 R
/On 918 0 R
>>
/N <<
/On 919 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [165.993 430.933 179.313 441.373]
/Subtype /Widget
/T (S08QA404A_20613)
/TU (Require diagnosis)
/Type /Annot
/V /Off
>>
endobj
259 0 obj
<<
/AP <<
/D <<
/Off 920 0 R
/On 921 0 R
>>
/N <<
/On 922 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [166.32 412.235 179.64 422.675]
/Subtype /Widget
/T (S08QA404A_20614)
/TU (Require PDMP checks)
/Type /Annot
/V /Off
>>
endobj
260 0 obj
<<
/AP <<
/D <<
/Off 923 0 R
/On 924 0 R
>>
/N <<
/On 925 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [166.32 394.253 179.64 404.693]
/Subtype /Widget
/T (S08QA404A_20615)
/TU (Workgroups to address opioids)
/Type /Annot
/V /Off
>>
endobj
261 0 obj
<<
/AP <<
/D <<
/Off 926 0 R
/On 927 0 R
>>
/N <<
/On 928 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 895 0 R
/Rect [166.32 375.962 179.64 386.402]
/Subtype /Widget
/T (S08QA404A_20616)
/TU (Other)
/Type /Annot
/V /On
>>
endobj
262 0 obj
<<
/AP <<
/N 929 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 895 0 R
/Rect [170.527 279.724 542.345 352.894]
/Subtype /Widget
/T (S08QA44A1)
/TU (If "Other," please explain what additional opioid prescribing controls are in place.)
/Type /Annot
/V (All of the following criteria must be met in order for a recipient to exceed the number of seven-day prescriptions, to exceed the seven-day limit or to exceed the 60 mg morphine equivalents or less per day; if the recipient has chronic pain or requires extended opioid therapy and is under the supervision of a licensed prescriber, if the pain cannot be controlled through the use of non-opioid therapy \(acetaminophen, NSAIDs, antidepressants, anti-seizure medications, physical therapy, etc.\); the lowest effective dose is being requested and a pain contract is on file. )
>>
endobj
263 0 obj
<<
/AP <<
/N 930 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 895 0 R
/Rect [149.254 156.015 543.909 229.185]
/Subtype /Widget
/T (S08QA404B)
/TU (If "Other," please explain what you do in lieu of the above or why you do not have measures in place to either manage or monitor the prescribing of opioids.)
/Type /Annot
>>
endobj
264 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [931 0 R 932 0 R]
/T (S08QA40N5)
/TU (Do you have POS edits to monitor duplicate therapy of opioid prescriptions?)
/V /Yes
>>
endobj
265 0 obj
<<
/AP <<
/N 933 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 934 0 R
/Rect [145.365 556.408 540.722 629.577]
/Subtype /Widget
/T (S08QA4N5A)
/TU (Please explain.)
/Type /Annot
/V (Pro-DUR edits are in place to monitor duplicate therapy. )
>>
endobj
266 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [935 0 R 936 0 R]
/T (S08QA40N6)
/TU (Do you have POS edits to monitor early refills of opioid prescriptions dispensed?)
/V /Yes
>>
endobj
267 0 obj
<<
/AP <<
/N 937 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 934 0 R
/Rect [146.674 383.654 542.031 456.823]
/Subtype /Widget
/T (S08QA4N6A)
/TU (Please explain.)
/Type /Annot
/V (Refill limits are set to 90% of previous fill must be used. )
>>
endobj
268 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [938 0 R 939 0 R]
/T (S08QA40N7)
/TU (Do you have comprehensive claims review automated retrospective process to monitor opioid prescriptions exceeding these state limitations?)
/V /No
>>
endobj
269 0 obj
<<
/AP <<
/N 940 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 934 0 R
/Rect [147.52 187.145 542.877 260.314]
/Subtype /Widget
/T (S08QA4N7A)
/TU (Please explain.)
/Type /Annot
/V (RetroDUR is a manual review process and opioid reports are presented to the DUR Board. )
>>
endobj
270 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [941 0 R 942 0 R 943 0 R 944 0 R]
/T (S08QA4005)
/TU (Do you currently have POS edits in place or a retrospective claims review to monitor opioids and benzodiazepines being used concurrently?)
/V /Yes#2C#20both#20POS#20edits#20and#20retrospective#20reviews
>>
endobj
271 0 obj
<<
/AP <<
/N 945 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 946 0 R
/Rect [148.285 523.87 543.642 597.039]
/Subtype /Widget
/T (S08QA4N8A)
/TU (Please explain in detail scope and nature of reviews and edits.)
/Type /Annot
/V (ProDUR edits are in place to warn of combination of opioids and benzodiazepines. The RetroDUR program includes initiatives to address the combination of opioids and benzodiazepines. )
>>
endobj
272 0 obj
<<
/AP <<
/N 947 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 946 0 R
/Rect [147.594 406.707 542.951 479.876]
/Subtype /Widget
/T (S08QA4N8B)
/TU ("No," please explain.)
/Type /Annot
>>
endobj
273 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [948 0 R 949 0 R 950 0 R 951 0 R]
/T (S08QA40N9)
/TU (Do you currently have POS edits in place or a retrospective claims review to monitor opioids and sedatives being used concurrently?)
/V /Yes#2C#20POS#20edits#20only
>>
endobj
274 0 obj
<<
/AP <<
/N 952 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 946 0 R
/Rect [148.285 201.507 543.642 274.676]
/Subtype /Widget
/T (S08QA4N9A)
/TU (Please explain in detail scope and nature of reviews and edits.)
/Type /Annot
/V (ProDUR edits are in place to warn of the combination of opioids and sedatives being used concurrently. )
>>
endobj
275 0 obj
<<
/AP <<
/N 953 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 946 0 R
/Rect [148.576 84.6705 543.933 157.839]
/Subtype /Widget
/T (S08QA4N9B)
/TU ("No," please explain)
/Type /Annot
>>
endobj
276 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [954 0 R 955 0 R 956 0 R 957 0 R]
/T (S08QA4N10)
/TU (Do you currently have POS edits in place or a retrospective claims review to monitor opioids and antipsychotics being used concurrently?)
/V /Yes#2C#20both#20POS#20edits#20and#20retrospective#20reviews
>>
endobj
277 0 obj
<<
/AP <<
/N 958 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 959 0 R
/Rect [148.209 509.625 543.566 582.794]
/Subtype /Widget
/T (S08QA4NAA)
/TU (Please explain in detail scope and nature of reviews and edits.)
/Type /Annot
/V (POS claims are edited with ProDUR edits set to warn pharmacists of the combination of opioids and antipsychotics. RetroDUR activities include letters and information to prescribers for the combination of opioids and antipsychotics. )
>>
endobj
278 0 obj
<<
/AP <<
/N 960 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 959 0 R
/Rect [148.5 392.789 543.857 465.958]
/Subtype /Widget
/T (S08QA4NAB)
/TU ("No," please explain)
/Type /Annot
>>
endobj
279 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [961 0 R 962 0 R 963 0 R 964 0 R]
/T (S08QA4006)
/TU (Do you have POS safety edits or perform RetroDUR activity and/or provider education in regard to beneficiaries with a diagnosis history of opioid use disorder \(OUD\) or opioid poisoning diagnosis?)
/V /Yes#2C#20retrospective#20reviews#20only
>>
endobj
280 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [965 0 R 966 0 R 967 0 R 968 0 R 969 0 R 970 0 R]
/T (S08QA406A)
/TU (If "Yes," please indicate how often.)
/V /Ad#20hoc
>>
endobj
281 0 obj
<<
/AP <<
/N 971 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 972 0 R
/Rect [185.952 301.742 541.538 374.911]
/Subtype /Widget
/T (S08QA46A1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
282 0 obj
<<
/AP <<
/N 973 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 972 0 R
/Rect [142.77 176.961 540.575 250.13]
/Subtype /Widget
/T (S08QA4B6B)
/TU (Please explain nature and scope of edits, reviews and/or provider education reviews performed.)
/Type /Annot
/V (RetroDUR activities include letters and information to prescribers providing for members with opioid use disorder and who are receiving an opioid. )
>>
endobj
283 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [974 0 R 975 0 R]
/T (S08QA406B)
/TU (If "No," do you plan on implementing a RetroDUR activity and/or provider education in regard to beneficiaries with a diagnosis or history of OUD, or opioid poisoning in the future?)
>>
endobj
284 0 obj
<<
/AP <<
/N 976 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 977 0 R
/Rect [174.516 524.961 541.884 598.13]
/Subtype /Widget
/T (S08QA4BA1)
/TU (Please explain.)
/Type /Annot
>>
endobj
285 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [978 0 R 979 0 R]
/T (S08QA4007)
/TU (Does your state Medicaid agency develop and provide prescribers with pain management or opioid prescribing guidelines?)
/V /Yes
>>
endobj
286 0 obj
<<
/AP <<
/D <<
/Off 980 0 R
/On 981 0 R
>>
/N <<
/On 982 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 977 0 R
/Rect [172.467 370.731 185.787 381.171]
/Subtype /Widget
/T (S08QA407A_20085)
/TU (Your state Medicaid agency refers prescribers to the CDC's Guideline for Prescribing Opioids for Chronic Pain.)
/Type /Annot
/V /On
>>
endobj
287 0 obj
<<
/AP <<
/D <<
/Off 983 0 R
/On 984 0 R
>>
/N <<
/On 985 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 977 0 R
/Rect [172.031 332.646 185.351 343.086]
/Subtype /Widget
/T (S08QA407A_20086)
/TU (Other guidelines)
/Type /Annot
/V /Off
>>
endobj
288 0 obj
<<
/AP <<
/D <<
/Off 986 0 R
/On 987 0 R
>>
/N <<
/On 988 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 977 0 R
/Rect [170.158 203.646 183.26 214.086]
/Subtype /Widget
/T (S08QA407A_20087)
/TU (No guidelines are offered.)
/Type /Annot
/V /Off
>>
endobj
289 0 obj
<<
/AP <<
/N 989 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 977 0 R
/Rect [192.417 222.834 564.235 296.004]
/Subtype /Widget
/T (S08QA47A2)
/TU (Please explain why no guidelines are offered.)
/Type /Annot
>>
endobj
290 0 obj
<<
/AP <<
/N 990 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 977 0 R
/Rect [188.927 98.9074 560.745 172.077]
/Subtype /Widget
/T (S08QA47A1)
/TU (Please explain why no guidelines are offered.)
/Type /Annot
>>
endobj
291 0 obj
<<
/AP <<
/N 991 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 992 0 R
/Rect [165.701 551.245 561.058 624.414]
/Subtype /Widget
/T (S08QA408A)
/TU (If "Yes," please explain.)
/Type /Annot
/V (The preferred drug list contains a drug class specific to abuse deterrent opioids. Members do not have to try a non-abuse deterrent opioid prior to gaining access to abuse deterrent opioids. )
>>
endobj
292 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [993 0 R 994 0 R]
/T (S08QA4008)
/TU (Do you have a drug utilization management strategy that supports abuse deterrent opioid use to prevent opioid misuse and abuse \(i.e. presence of an abuse deterrent opioid with preferred status on your preferred drug list\)?)
/V /Yes
>>
endobj
293 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [995 0 R 996 0 R]
/T (S08QA5001)
/TU (What is your maximum morphine equivalent daily dose limit in milligrams?)
/V /Yes
>>
endobj
294 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [997 0 R 998 0 R 999 0 R 1000 0 R 1001 0 R 1002 0 R 1003 0 R 1004 0 R]
/T (S08QA501A)
/TU (What is your maximum morphine equivalent daily dose limit in milligrams?)
/V /Other
>>
endobj
295 0 obj
<<
/DA (/Helv 8 Tf 0 g)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/P 1005 0 R
/Q 1
/Rect [216.818 424.756 288.454 440.808]
/Subtype /Widget
/T (S08QA51A1)
/TU (Other mg per day)
/Type /Annot
/V (60)
/AP 1006 0 R
>>
endobj
296 0 obj
<<
/AP <<
/N 1007 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1005 0 R
/Rect [160.249 311.47 555.606 384.639]
/Subtype /Widget
/T (S08QA51A2)
/TU (Please explain nature and scope of dose limit.)
/Type /Annot
/V (The MME limit applies to all oral opioid products. )
>>
endobj
297 0 obj
<<
/AP <<
/N 1008 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1005 0 R
/Rect [143.994 204.452 556.369 277.621]
/Subtype /Widget
/T (S08QA510B)
/TU (Please explain the measure or program you utilize.)
/Type /Annot
>>
endobj
298 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1009 0 R 1010 0 R]
/T (S08QA5002)
/TU (Please name the developer of the calculator)
/V /Yes
>>
endobj
299 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1011 0 R 1012 0 R 1013 0 R]
/T (S08QA5020)
/TU (Please name the developer of the calculator)
/V /CDC
>>
endobj
300 0 obj
<<
/AP <<
/N 1014 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1015 0 R
/Rect [184.53 474.742 539.725 497.84]
/Subtype /Widget
/T (S08QA520A)
/TU (Other, please specify)
/Type /Annot
>>
endobj
301 0 obj
<<
/AP <<
/D <<
/Off 1016 0 R
/On 1017 0 R
>>
/N <<
/On 1018 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1015 0 R
/Rect [162.54 420.027 175.86 430.467]
/Subtype /Widget
/T (S08QA520B_20088)
/TU (How is the information disseminated? Check all that apply: Website)
/Type /Annot
/V /On
>>
endobj
302 0 obj
<<
/AP <<
/D <<
/Off 1019 0 R
/On 1020 0 R
>>
/N <<
/On 1021 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1015 0 R
/Rect [162.54 399.027 175.86 409.794]
/Subtype /Widget
/T (S08QA520B_20089)
/TU (Provider notice)
/Type /Annot
/V /On
>>
endobj
303 0 obj
<<
/AP <<
/D <<
/Off 1022 0 R
/On 1023 0 R
>>
/N <<
/On 1024 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1015 0 R
/Rect [162.54 378.777 175.86 389.217]
/Subtype /Widget
/T (S08QA520B_20090)
/TU (Educational seminar)
/Type /Annot
/V /Off
>>
endobj
304 0 obj
<<
/AP <<
/D <<
/Off 1025 0 R
/On 1026 0 R
>>
/N <<
/On 1027 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1015 0 R
/Rect [163.194 357.261 176.514 367.701]
/Subtype /Widget
/T (S08QA520B_20091)
/TU (Other)
/Type /Annot
/V /Off
>>
endobj
305 0 obj
<<
/AP <<
/N 1028 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1015 0 R
/Rect [183.499 263.561 544.355 336.731]
/Subtype /Widget
/T (S08QA52B1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
306 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1029 0 R 1030 0 R]
/T (S08QA5003)
/TU (Do you have automated retrospective claim reviews to monitor total daily dose \(MME\) of opioid prescriptions dispensed?)
/V /Yes
>>
endobj
307 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1031 0 R 1032 0 R]
/T (S08QA503A)
/TU (If "Yes," do you require prior authorization if the MEDD limit is exceeded?)
/V /Yes
>>
endobj
308 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1033 0 R 1034 0 R]
/T (S08QA5004)
/TU (Do you have automated retrospective claim reviews to monitor total daily dose \(MME\) of opioid prescriptions dispensed?)
/V /No
>>
endobj
309 0 obj
<<
/AP <<
/N 1035 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1036 0 R
/Rect [148.154 544.579 542.064 617.749]
/Subtype /Widget
/T (S08QA504A)
/TU (If "Other," please explain.)
/Type /Annot
/V (The retrospective claim review is a manual review process through the retroDUR program and DUR meeting presentations. )
>>
endobj
310 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1037 0 R 1038 0 R]
/T (S08QA6001)
/TU (Does your agency set total mg per day limits on the use of buprenorphine and buprenorphine/naloxone combination drugs?)
/V /Yes
>>
endobj
311 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1039 0 R 1040 0 R 1041 0 R 1042 0 R 1043 0 R]
/T (S08QA601A)
/TU (What are your limitations on the allowable length of this treatment?)
/V /24#20mg
>>
endobj
312 0 obj
<<
/AP <<
/N 1044 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1036 0 R
/Rect [170.509 157.652 541.637 230.821]
/Subtype /Widget
/T (S08QA61A1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
313 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1045 0 R 1046 0 R 1047 0 R 1048 0 R 1049 0 R 1050 0 R]
/T (S08QA6002)
/TU (What are your limitations on the allowable length of this treatment?)
/V /No#20limit
>>
endobj
314 0 obj
<<
/AP <<
/N 1051 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1052 0 R
/Rect [147.392 473.052 540.934 546.221]
/Subtype /Widget
/T (S08QA602A)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
315 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1053 0 R 1054 0 R]
/T (S08QA6003)
/TU (Do you require that the maximum mg per day allowable be reduced after a set period of time?)
/V /No
>>
endobj
316 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1055 0 R 1056 0 R 1057 0 R 1058 0 R]
/T (S08QA603A)
/TU (If "Yes," what is your reduced \(maintenance\) dosage?)
>>
endobj
317 0 obj
<<
/AP <<
/N 1059 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1052 0 R
/Rect [188.214 130.161 547.494 203.33]
/Subtype /Widget
/T (S08QA63A1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
318 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1060 0 R 1061 0 R 1062 0 R 1063 0 R]
/T (S08QA603B)
/TU (What are your limitations on the allowable length of this treatment?)
>>
endobj
319 0 obj
<<
/AP <<
/N 1064 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1065 0 R
/Rect [188.214 508.488 547.494 581.657]
/Subtype /Widget
/T (S08QA63B1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
320 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1066 0 R 1067 0 R]
/T (S08QA6004)
/TU (Do you have at least one buprenorphine/naloxone combination product available without prior authorization?)
/V /Yes
>>
endobj
321 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1068 0 R 1069 0 R 1070 0 R]
/T (S08QA6005)
/TU (Do you currently have edits in place to monitor opioids being used concurrently with any buprenorphine drug?)
/V /No
>>
endobj
322 0 obj
<<
/AP <<
/N 1071 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1065 0 R
/Rect [148.411 204.181 541.066 277.35]
/Subtype /Widget
/T (S08QA605B)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
323 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1072 0 R 1073 0 R]
/T (S08QA605A)
/TU (If "Yes," can the POS pharmacist override the edit?)
>>
endobj
324 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1074 0 R 1075 0 R]
/T (S08QA6006)
/TU (Do you have at least one naloxone opioid overdose product available without prior authorization?)
/V /Yes
>>
endobj
325 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1076 0 R 1077 0 R]
/T (S08QA60N7)
/TU (Does your state board of pharmacy and/or state Medicaid agency allow pharmacists to dispense naloxone prescribed independently or by collaborative practice agreements, standing orders, or other predetermined protocols?)
/V /Yes
>>
endobj
326 0 obj
<<
/AP <<
/N 1078 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1079 0 R
/Rect [148.29 459.725 540.945 532.894]
/Subtype /Widget
/T (S08QA6N7A)
/TU (If "No," please explain.)
/Type /Annot
/V (RetroDUR activities include review of high-dose opioids without naloxone rescue. )
>>
endobj
327 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1080 0 R 1081 0 R 1082 0 R]
/T (S08QA6007)
/TU (Does your State Board of Professional Regulations/Board of Pharmacy/Board of Medicine and/or state Medicaid agency allow pharmacists to dispense naloxone prescribed independently or by collaborative practice agreements, standing orders, or other predetermined protocols?)
/V /Yes#2C#20State#20Board#20of#20Professional#20Regulations#2FBoard#20of#20Pharmacy#2F#20Board#20of#20Medicine#20and#2For#20State#20Medicaid#20agency#20under#20protocol
>>
endobj
328 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1083 0 R 1084 0 R]
/T (S08QA6008)
/TU (Does your state agency cover Methadone for a substance use disorder \(i.e. Methadone Treatment Center\)?)
/V /Yes
>>
endobj
329 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1085 0 R 1086 0 R]
/T (S08QA7001)
/TU (Do you currently have restrictions in place to limit the quantity of antipsychotics?)
/V /Yes
>>
endobj
330 0 obj
<<
/AP <<
/N 1087 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1088 0 R
/Rect [126.19 489.302 543.445 562.471]
/Subtype /Widget
/T (S08QA701A)
/TU (If "No," please explain.)
/Type /Annot
/V (Children under age 18 years-old are allowed one antipsychotic without prior authorization.)
>>
endobj
331 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1089 0 R 1090 0 R]
/T (S08QA7002)
/TU (Do you have a documented program in place to either manage or monitor the appropriate use of antipsychotic drugs in children?)
/V /Yes
>>
endobj
332 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1091 0 R 1092 0 R 1093 0 R]
/T (S08QA702A)
/TU (Do you currently have edits in place to monitor opioids being used concurrently with any buprenorphine drug?)
/V /All#20children
>>
endobj
333 0 obj
<<
/AP <<
/N 1094 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1088 0 R
/Rect [187.606 159.122 544.179 232.291]
/Subtype /Widget
/T (S08QA72A1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
334 0 obj
<<
/AP <<
/D <<
/Off 1095 0 R
/On 1096 0 R
>>
/N <<
/On 1097 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1098 0 R
/Rect [162.214 682.989 175.534 693.429]
/Subtype /Widget
/T (S08QA702B_20654)
/TU (Do you have edits in place to monitor \(check all that apply\): Child's Age)
/Type /Annot
/V /On
>>
endobj
335 0 obj
<<
/AP <<
/D <<
/Off 1099 0 R
/On 1100 0 R
>>
/N <<
/On 1101 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1098 0 R
/Rect [162.214 661.989 175.534 672.429]
/Subtype /Widget
/T (S08QA702B_20655)
/TU (Dosage)
/Type /Annot
/V /Off
>>
endobj
336 0 obj
<<
/AP <<
/D <<
/Off 1102 0 R
/On 1103 0 R
>>
/N <<
/On 1104 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1098 0 R
/Rect [162.214 641.739 175.534 652.179]
/Subtype /Widget
/T (S08QA702B_20656)
/TU (Polypharmacy)
/Type /Annot
/V /On
>>
endobj
337 0 obj
<<
/AP <<
/D <<
/Off 1105 0 R
/On 1106 0 R
>>
/N <<
/On 1107 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1098 0 R
/Rect [162.869 621.224 176.189 631.664]
/Subtype /Widget
/T (S08QA702B_20657)
/TU (Other)
/Type /Annot
/V /On
>>
endobj
338 0 obj
<<
/AP <<
/D <<
/Off 1108 0 R
/On 1109 0 R
>>
/N <<
/On 1110 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1098 0 R
/Rect [162.867 601.053 176.187 611.493]
/Subtype /Widget
/T (S08QA702B_20658)
/TU (Other)
/Type /Annot
/V /Off
>>
endobj
339 0 obj
<<
/AP <<
/N 1111 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1098 0 R
/Rect [183.88 502.597 544.737 575.767]
/Subtype /Widget
/T (S08QA72B1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
340 0 obj
<<
/AP <<
/N 1112 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1098 0 R
/Rect [161.361 381.506 542.965 454.676]
/Subtype /Widget
/T (S08QA702C)
/TU (Please briefly explain the specifics of your antipsychotic monitoring program\(s\).)
/Type /Annot
/V (Recipients under 18 years old are limited to a single anti-psychotic without PA. Children under 18 years of age are allowed one product from three of the following classes \(antipsychotic, sedative/hypnotic, anticonvulsant, antidepressant or benzodiazepine\) without prior authorization. The fourth medication requires prior authorization and two or more medications within the same class require prior authorization. All antipsychotics for children under six years of age require prior authorization.)
>>
endobj
341 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1113 0 R 1114 0 R]
/T (S08QA702D)
/TU (If "No," do you plan on implementing a program in the future?)
>>
endobj
342 0 obj
<<
/AP <<
/N 1115 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1098 0 R
/Rect [158.727 217.87 540.327 291.039]
/Subtype /Widget
/T (S08QA72D2)
/TU (If "No," please explain why you will not be implementing a program to monitor the appropriate use of antipsychotic drugs in children.)
/Type /Annot
>>
endobj
343 0 obj
<<
/AP <<
/N 1116 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1098 0 R
/Rect [161.018 67.6523 542.618 140.821]
/Subtype /Widget
/T (S08QA72D1)
/TU (If "No," please explain why you will not be implementing a program to monitor the appropriate use of antipsychotic drugs in children.)
/Type /Annot
>>
endobj
344 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1117 0 R 1118 0 R]
/T (S08QA7003)
/TU (Do you currently have restrictions in place to limit the quantity of stimulants?)
/V /Yes
>>
endobj
345 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1119 0 R 1120 0 R]
/T (S08QA7004)
/TU (Do you have a documented program in place to either manage or monitor the appropriate use of stimulant drugs in children?)
/V /Yes
>>
endobj
346 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1121 0 R 1122 0 R 1123 0 R]
/T (S08QA704A)
/TU (All children)
/V /All#20children
>>
endobj
347 0 obj
<<
/AP <<
/N 1124 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1125 0 R
/Rect [188.812 334.306 545.384 391.725]
/Subtype /Widget
/T (S08QA74A1)
/TU (If "Other," please explain.)
/Type /Annot
>>
endobj
348 0 obj
<<
/AP <<
/D <<
/Off 1126 0 R
/On 1127 0 R
>>
/N <<
/On 1128 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1125 0 R
/Rect [162.54 284.889 175.86 295.329]
/Subtype /Widget
/T (S08QA704B_20654)
/TU (Do you have edits in place to monitor \(check all that apply\): Child's Age)
/Type /Annot
/V /On
>>
endobj
349 0 obj
<<
/AP <<
/D <<
/Off 1129 0 R
/On 1130 0 R
>>
/N <<
/On 1131 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1125 0 R
/Rect [162.867 263.944 176.187 274.384]
/Subtype /Widget
/T (S08QA704B_20655)
/TU (Do you have edits in place to monitor \(check all that apply\): Child's Age)
/Type /Annot
/V /On
>>
endobj
350 0 obj
<<
/AP <<
/D <<
/Off 1132 0 R
/On 1133 0 R
>>
/N <<
/On 1134 0 R
>>
>>
/AS /On
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1125 0 R
/Rect [162.849 243.98 176.169 254.42]
/Subtype /Widget
/T (S08QA704B_20656)
/TU (Do you have edits in place to monitor \(check all that apply\): Child's Age)
/Type /Annot
/V /On
>>
endobj
351 0 obj
<<
/AP <<
/D <<
/Off 1135 0 R
/On 1136 0 R
>>
/N <<
/On 1137 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1125 0 R
/Rect [162.504 223.417 175.824 233.857]
/Subtype /Widget
/T (S08QA704B_20657)
/TU (Do you have edits in place to monitor \(check all that apply\): Child's Age)
/Type /Annot
/V /Off
>>
endobj
352 0 obj
<<
/AP <<
/D <<
/Off 1138 0 R
/On 1139 0 R
>>
/N <<
/On 1140 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1125 0 R
/Rect [163.449 202.508 176.769 212.62]
/Subtype /Widget
/T (S08QA704B_20658)
/TU (Do you have edits in place to monitor \(check all that apply\): Child's Age)
/Type /Annot
/V /Off
>>
endobj
353 0 obj
<<
/AP <<
/N 1141 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1125 0 R
/Rect [183.864 108.146 563.663 165.746]
/Subtype /Widget
/T (S08QA74B1)
/TU (Please briefly explain the specifics of your documented stimulant monitoring program\(s\).)
/Type /Annot
>>
endobj
354 0 obj
<<
/AP <<
/N 1142 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1143 0 R
/Rect [161.591 582.546 541.39 640.146]
/Subtype /Widget
/T (S08QA704C)
/TU (Please briefly explain the specifics of your documented stimulant monitoring program\(s\).)
/Type /Annot
/V (Prior authorization is required for all stimulant use for children. More than one agent including more than one long-acting agent requires prior authorization and clinical justification. )
>>
endobj
355 0 obj
<<
/AP <<
/N 1144 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1143 0 R
/Rect [157.46 410.634 536.357 483.803]
/Subtype /Widget
/T (S08QA74D2)
/TU (If "Yes," when do you plan on implementing a program?)
/Type /Annot
>>
endobj
356 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1145 0 R 1146 0 R]
/T (S08QA704D)
/TU (Do you have a documented program in place to either manage or monitor the appropriate use of stimulant drugs in children?)
>>
endobj
357 0 obj
<<
/AP <<
/N 1147 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1143 0 R
/Rect [161.504 268.592 540.401 341.761]
/Subtype /Widget
/T (S08QA74D1)
/TU (Summary 6 - Innovative Practices)
/Type /Annot
>>
endobj
358 0 obj
<<
/AP <<
/N 1148 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1149 0 R
/Rect [124.296 378.18 540.284 553.458]
/Subtype /Widget
/T (S09Q00001)
/TU (Summary 6 - Innovative Practices)
/Type /Annot
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
>>
endobj
359 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1150 0 R 1151 0 R]
/T (S10Q00001)
/TU (Does your MMIS or pharmacy vendor have a portal to electronically provide patient drug history data and pharmacy coverage limitations to a prescriber prior to prescribing upon inquiry?)
/V /Yes
>>
endobj
360 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1152 0 R 1153 0 R]
/T (S10Q0001A)
/TU (If "Yes," do you have a methodology to evaluate the effectiveness of providing drug information and medication history prior to prescribing?)
/V /Yes
>>
endobj
361 0 obj
<<
/AP <<
/N 1154 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1155 0 R
/Rect [170.551 314.415 549.448 400.349]
/Subtype /Widget
/T (S10Q01A02)
/TU (Summary 6 - Innovative Practices)
/Type /Annot
/V (As of September 2019, approximately 59% of all prescriptions are transmitted through an ePrescribing platform. This trend continues to grow into FFY2020. As of September 2019, approximately 40% of prescribers have adopted an ePrescribing tool. There were a total of 3,024,742 eligibility checks and a total of 3,784,107 medication history transaction requests between October 1, 2018 and September 30, 2019. Cost-savings evaluation was not performed for this period. In FFY20, an ePA tool should be available to providers. This tool works with ePrescribe and will increase the number of electronic prescriptions.)
>>
endobj
362 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1156 0 R 1157 0 R]
/T (S10Q0001B)
/TU (If "No," are you planning to develop this capability?)
>>
endobj
363 0 obj
<<
/AP <<
/N 1158 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1155 0 R
/Rect [170.879 92.5247 541.266 178.458]
/Subtype /Widget
/T (S10Q001BA)
/TU (If "No," please explain)
/Type /Annot
>>
endobj
364 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1159 0 R 1160 0 R]
/T (S10Q00002)
/TU (Does your system use the NCPDP Origin Code that indicates the prescription source?)
/V /Yes
>>
endobj
365 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
>>
/MaxLen 300000
/P 1161 0 R
/Rect [126.313 560.825 253.325 582.664]
/Subtype /Widget
/T (S11Q00001)
/TU (How many MCOs are enrolled in your state Medicaid program?)
/Type /Annot
/V (3)
/AP 1162 0 R
>>
endobj
366 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1163 0 R 1164 0 R 1165 0 R]
/T (S11Q00002)
/TU (Is your pharmacy program included in the capitation rate \(carved in\)?)
/V /No
>>
endobj
367 0 obj
<<
/AP <<
/N 1166 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1161 0 R
/Rect [147.992 344.386 541.315 411.18]
/Subtype /Widget
/T (S11Q0002A)
/TU (If "Partial," please specify the drug categories that are carved out.)
/Type /Annot
>>
endobj
368 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1167 0 R 1168 0 R]
/T (S11Q00003)
/TU (Does the state set requirements for the MCO's pharmacy benefit \(e.g. same PDL, same ProDUR/RetroDUR\)?)
/V /No
>>
endobj
369 0 obj
<<
/AP <<
/D <<
/Off 1169 0 R
/On 1170 0 R
>>
/N <<
/On 1171 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1161 0 R
/Rect [163.031 166.054 176.351 176.494]
/Subtype /Widget
/T (S11Q03A01_20659)
/TU (Please check all requirements that apply below: Formulary Reviews)
/Type /Annot
/V /Off
>>
endobj
370 0 obj
<<
/AP <<
/D <<
/Off 1172 0 R
/On 1173 0 R
>>
/N <<
/On 1174 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1161 0 R
/Rect [163.031 146.054 176.351 156.494]
/Subtype /Widget
/T (S11Q03A01_20660)
/TU (Same PDL)
/Type /Annot
/V /Off
>>
endobj
371 0 obj
<<
/AP <<
/D <<
/Off 1175 0 R
/On 1176 0 R
>>
/N <<
/On 1177 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1161 0 R
/Rect [163.031 124.804 176.351 135.244]
/Subtype /Widget
/T (S11Q03A01_20661)
/TU (Same ProDUR)
/Type /Annot
/V /Off
>>
endobj
372 0 obj
<<
/AP <<
/D <<
/Off 1178 0 R
/On 1179 0 R
>>
/N <<
/On 1180 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1161 0 R
/Rect [163.031 104.306 176.351 114.746]
/Subtype /Widget
/T (S11Q03A01_20662)
/TU (No state PDL)
/Type /Annot
/V /Off
>>
endobj
373 0 obj
<<
/AP <<
/D <<
/Off 1181 0 R
/On 1182 0 R
>>
/N <<
/On 1183 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1161 0 R
/Rect [163.358 83.5713 176.678 94.0114]
/Subtype /Widget
/T (S11Q03A01_20663)
/TU (Same RetroDUR)
/Type /Annot
/V /Off
>>
endobj
374 0 obj
<<
/AP <<
/N 1184 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1185 0 R
/Rect [161.841 625.161 543.322 698.331]
/Subtype /Widget
/T (S11Q03A02)
/TU (If "Yes," please briefly explain your policy.)
/Type /Annot
>>
endobj
375 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1186 0 R 1187 0 R]
/T (S11Q0003B)
/TU (If "No," do you plan to set standards in the future?)
/V /Yes
>>
endobj
376 0 obj
<<
/AP <<
/N 1188 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1185 0 R
/Rect [165.127 449.524 560.109 522.694]
/Subtype /Widget
/T (S10Q003B1)
/TU (If "No," please explain)
/Type /Annot
>>
endobj
377 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1189 0 R 1190 0 R]
/T (S11Q00004)
/TU (Did all of your managed care plans submit their DUR reports?)
/V /Yes
>>
endobj
378 0 obj
<<
/AP <<
/N 1191 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1185 0 R
/Rect [148.109 264.015 543.09 337.185]
/Subtype /Widget
/T (S11Q0004A)
/TU (If "No," please explain Why.)
/Type /Annot
>>
endobj
379 0 obj
<<
/AP <<
/N 1192 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1193 0 R
/Rect [125.2 487.543 541.781 626.494]
/Subtype /Widget
/T (S12Q00002)
/TU (If "No," please explain Why.)
/Type /Annot
/V <5468652044727567205573652052657669657720426F617264202844555229206973206120726571756972656D656E74206F662074686520536F6369616C205365637572697479204163742C2053656374696F6E203139323720616E64206F7065726174657320696E206163636F7264616E63652077697468204E6576616461204D65646963616964205365727669636573204D616E75616C2C204368617074657220313230302C20507265736372696265642044727567732C20616E64204E6576616461204D65646963616964204F7065726174696F6E73204D616E75616C204368617074657220313230302E200A5468652044555220426F61726420636F6E7369737473206F66206E6F206C657373207468616E2066697665206D656D6265727320616E64206E6F206D6F7265207468616E2074656E206D656D62657273206170706F696E74656420627920746865205374617465204469726563746F72206F66204865616C746820616E642048756D616E205265736F75726365732E204D656D62657273206D757374206265206C6963656E73656420746F20707261637469636520696E20746865205374617465206F66204E657661646120616E642065697468657220616E206163746976656C792070726163746963696E672070687973696369616E206F7220616E206163746976656C792070726163746963696E6720706861726D61636973742E200A5468652044555220426F617264206D6565747320717561727465726C7920746F206D6F6E69746F7220647275677320666F723A20746865726170657574696320617070726F7072696174656E6573732C206F766572206F7220756E6465722D7574696C697A6174696F6E2C207468657261706575746963206475706C69636174696F6E732C20647275672D6469736561736520636F6E747261696E6469636174696F6E7320616E64207175616C69747920636172652E20205468652044555220426F61726420646F657320746869732062792065737461626C697368696E67207072696F7220617574686F72697A6174696F6E20616E64207175616E74697479206C696D69747320746F206365727461696E2064727567732F6472756720636C6173736573206261736564206F6E207574696C697A6174696F6E20646174612C20657870657269656E63652C20616E642074657374696D6F6E792070726573656E746564206174207468652044555220426F617264206D656574696E67732E205468697320696E636C7564657320726574726F7370656374697665206576616C756174696F6E206F6620696E74657276656E74696F6E732C20616E642070726F7370656374697665206472756720726576696577207468617420697320646F6E6520656C656374726F6E6963616C6C7920666F72206561636820707265736372697074696F6E2066696C6C65642061742074686520506F696E74206F662053616C652028504F53292E0A447572696E6720746865204665646572616C2046697363616C205965617220323031392C207468652044555220426F6172642077617320636F6D707269736564206F6620666976652070687973696369616E73202831207061696E207370656369616C6973742C2031207073796368696174726973742C2031206E6575726F6C6F676973742C203120696E7465726E616C206D65646963696E6520616E6420312066616D696C792070726163746963652070687973696369616E2920616E64206669766520706861726D61636973747320283220686F73706974616C20706861726D61636973747320616E64203320616D62756C61746F7279206361726520706861726D616369737473292066726F6D20766172696F7573206261636B67726F756E647320616E64206C6F636174696F6E732061726F756E6420746865205374617465206F66204E65766164612E20204F74686572206E6F6E2D766F74696E67206D656D626572732077686F20636F6E7472696275746520746F20426F6172642064697363757373696F6E7320696E636C75646520656D706C6F796565732066726F6D2044484346502C206120446570757479204174746F726E65792047656E6572616C20616E6420726570726573656E746174697665732066726F6D2074686520636F6E74726163746F727320666F72204D4D495320616E642050424D2073657276696365732E2020546865207468726565206D616E616765642063617265206F7267616E697A6174696F6E7320616C736F2070617274696369706174652C20616E6420656163682068617665206E6F6E2D766F74696E6720726570726573656E746174696F6E206F6E2074686520426F6172642E202020546865207075626C69632069732077656C636F6D6520746F2070726F766964652074657374696D6F6E7920746F2074686520626F617264206265666F7265207468657920766F7465206F6E20746F706963732E0A436C696E6963616C207265766965777320616E642070726F706F736564207072696F7220617574686F72697A6174696F6E20637269746572696120666F722074686520426F6172642061726520737570706C696564206279204F7074756D52782E20204164646974696F6E616C20696E7075742069732070726F766964656420627920706861726D61636575746963616C206D616E756661637475726572732C206D656D62657273206F6620746865207075626C696320616E64207468652044555220426F6172647320756E6971756520657870657269656E63657320616E642072657365617263682E200A416C6C2044555220426F617264206D656574696E6720696E666F726D6174696F6E20697320706F73746564206F6E207468652066697363616C206167656E742773207765627369746520666F7220746865207075626C6963206265666F72652065616368206D656574696E672E205468697320696E636C7564657320616C6C20636C696E6963616C206472756720726576696577732C206D656574696E67206D6174657269616C7320616E642070726F706F7365642063726974657269612E2020>
>>
endobj
380 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1194 0 R 1195 0 R]
/T (S02Q005YB)
/TU (Do you follow up with those providers who routinely override with interventions?)
>>
endobj
381 0 obj
<<
/AP <<
/N 1196 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1197 0 R
/Rect [201.392 496.573 543.899 551.124]
/Subtype /Widget
/T (S02Q5YBYO)
/TU (Please explain.)
/Type /Annot
>>
endobj
382 0 obj
<<
/AP <<
/N 1198 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1197 0 R
/Rect [184.158 398.858 544.106 453.409]
/Subtype /Widget
/T (S02Q05YBN)
/TU (Please explain.)
/Type /Annot
>>
endobj
383 0 obj
<<
/DA (/ZaDb 0 Tf 0 0 1 rg)
/FT /Btn
/Ff 49153
/Kids [1199 0 R 1200 0 R]
/T (S02Q00005)
/TU (Do you receive and review follow-up periodic reports providing individual pharmacy provider activity in summary and/or in detail?)
/V /No
>>
endobj
384 0 obj
<<
/AP <<
/N 1201 0 R
>>
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 4097
/MK <<
/BC [0.75 0.75 0.75]
/BG [1.0 1.0 1.0]
>>
/MaxLen 300000
/P 1197 0 R
/Rect [146.331 297.055 544.639 351.099]
/Subtype /Widget
/T (S02Q0005N)
/TU (If No is selected for receiving or reviewing of follow-up periodic reports, please explain.)
/Type /Annot
/V (A process to identify individual pharmacy provider DUR alert override activity in summary and/or in detail has not yet been implemented. )
>>
endobj
385 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 1197 0 R
/Q 2
/Rect [165.732 198.467 217.004 220.307]
/Subtype /Widget
/T (S02Q006A1)
/TU (Percentage threshold for non-controlled drugs)
/Type /Annot
/V (80)
/AP 1202 0 R
>>
endobj
386 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 1197 0 R
/Q 2
/Rect [166.831 152.627 217.653 174.467]
/Subtype /Widget
/T (S02Q006A2)
/TU (Percentage threshold for Schedule II controlled drugs)
/Type /Annot
/V (90)
/AP 1203 0 R
>>
endobj
387 0 obj
<<
/DA (/HeBo 10 Tf 0 0 1 rg)
/F 4
/FT /Tx
/Ff 12582913
/MK <<
>>
/P 1197 0 R
/Q 2
/Rect [168.144 107.442 221.344 129.282]
/Subtype /Widget
/T (S02Q006A3)
/TU (Percentage threshold for Schedule III through V controlled drugs)
/Type /Annot
/V (90)
/AP 1204 0 R
>>
endobj
388 0 obj
<<
/AP <<
/D <<
/Off 1205 0 R
/On 1206 0 R
>>
/N <<
/On 1207 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 489 0 R
/Rect [161.96 374.626 175.64 384.706]
/Subtype /Widget
/T (S02Q005YA_20126)
/TU (How Often?)
/Type /Annot
/V /Off
>>
endobj
389 0 obj
<<
/AP <<
/D <<
/Off 1208 0 R
/On 1209 0 R
>>
/N <<
/On 1210 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1197 0 R
/Rect [185.271 613.832 198.951 623.912]
/Subtype /Widget
/T (S02Q05YBY_20012)
/TU (Contact Pharmacy)
/Type /Annot
/V /Off
>>
endobj
390 0 obj
<<
/AP <<
/D <<
/Off 1211 0 R
/On 1212 0 R
>>
/N <<
/On 1213 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1197 0 R
/Rect [184.614 591.415 198.294 601.495]
/Subtype /Widget
/T (S02Q05YBY_20013)
/TU (Other)
/Type /Annot
/V /Off
>>
endobj
391 0 obj
<<
/AP <<
/D <<
/Off 1214 0 R
/On 1215 0 R
>>
/N <<
/On 1216 0 R
>>
>>
/AS /Off
/DA (/ZaDb 0 Tf 0 0 1 rg)
/F 4
/FT /Btn
/Ff 1
/MK <<
/CA (8)
>>
/P 1197 0 R
/Rect [184.614 568.833 198.294 578.913]
/Subtype /Widget
/T (S02Q05YBY_20014)
/TU (Other)
/Type /Annot
/V /Off
>>
endobj
392 0 obj
<<
/A 1217 0 R
/Count 0
/Next 1218 0 R
/Parent 4 0 R
/Title (ABOUT THE SURVEY)
>>
endobj
393 0 obj
<<
/A 1219 0 R
/Parent 4 0 R
/Prev 1220 0 R
/Title (XII. EXECUTIVE REPORT)
>>
endobj
394 0 obj
<<
/Count 30
/Kids [1221 0 R 1222 0 R 1223 0 R 1224 0 R 1225 0 R 1226 0 R]
/Parent 5 0 R
/Type /Pages
>>
endobj
395 0 obj
<<
/Count 25
/Kids [1227 0 R 1228 0 R 1229 0 R 1230 0 R 1231 0 R]
/Parent 5 0 R
/Type /Pages
>>
endobj
396 0 obj
<<
/K [1232 0 R 1233 0 R 1234 0 R 1235 0 R 1236 0 R]
/P 6 0 R
/S /Document
>>
endobj
397 0 obj
<<
/Nums [0 [null null null null 1237 0 R null null null null null
1238 0 R null null null null null null 1239 0 R null null
1240 0 R null null null 1241 0 R null null null 1242 0 R null
null 1243 0 R 1244 0 R null null null null null null 1245 0 R
null null null null null null 1246 0 R 1247 0 R 1248 0 R 1249 0 R
1250 0 R null null null 1251 0 R null null null null 1252 0 R
null null null null null 1253 0 R null null 1254 0 R null
null 1255 0 R null null 1256 0 R null null 1257 0 R null null
1258 0 R 1259 0 R]
1 [1260 0 R 1261 0 R 1262 0 R 1263 0 R 1264 0 R]
2 [1265 0 R 1266 0 R 1267 0 R 1268 0 R 1269 0 R 1270 0 R 1271 0 R 1272 0 R 1273 0 R 1274 0 R
1275 0 R 1276 0 R 1277 0 R null null null 1278 0 R null null null
1279 0 R null null null 1280 0 R null null null 1281 0 R 1282 0 R
null null null 1283 0 R null null null 1284 0 R 1285 0 R 1286 0 R
null null null null 1287 0 R null null null null 1288 0 R
1289 0 R]
3 [null null null null 1290 0 R null null null null null
1291 0 R null null null 1292 0 R null null null 1293 0 R null
null null null null null 1294 0 R null null null 1295 0 R
1296 0 R null null 1297 0 R null null 1298 0 R 1299 0 R 1300 0 R null
null null 1301 0 R null null null 1302 0 R 1303 0 R 1304 0 R 1305 0 R
1306 0 R]
4 [null null null 1307 0 R null null null 1308 0 R 1309 0 R 1310 0 R
1311 0 R 1312 0 R null null null 1313 0 R null null null 1314 0 R
null null null null 1315 0 R null null null null null
1316 0 R null null null 1317 0 R null null null 1318 0 R null
null null 1319 0 R null null null 1320 0 R null null 1321 0 R
1322 0 R 1323 0 R 1324 0 R]
6 [null null null null 1325 0 R null null null null 1326 0 R
null null null null null null 1327 0 R null null null
1328 0 R null null null 1329 0 R null null null null null
null 1330 0 R 1331 0 R 1332 0 R 1333 0 R 1334 0 R null null null null
null null 1335 0 R null null null 1336 0 R null null null
null null 1337 0 R null null null null 1338 0 R null null
null null null null 1339 0 R null null null 1340 0 R null
null null null null null 1341 0 R null null null null
null null 1342 0 R null null null 1343 0 R null null null
1344 0 R null null null null null null 1345 0 R null null
null null null null 1346 0 R null null null 1347 0 R null
null null null null null]
7 [null null null 1348 0 R null null null null 1349 0 R null
null null null null 1350 0 R null null null 1351 0 R null
null null 1352 0 R null null null null null 1353 0 R null
null null null null 1354 0 R null null null 1355 0 R null
null null 1356 0 R null null null null null null 1357 0 R
null null null null 1358 0 R null null null null 1359 0 R
null null null 1360 0 R null null null 1361 0 R 1362 0 R 1363 0 R
1364 0 R 1365 0 R]
8 [1366 0 R 1367 0 R 1368 0 R null null null 1369 0 R null null null
1370 0 R 1371 0 R null null null 1372 0 R null null null 1373 0 R
1374 0 R 1375 0 R 1376 0 R]
9 [null null null 1377 0 R null null null 1378 0 R 1379 0 R 1380 0 R
1381 0 R 1382 0 R 1383 0 R 1384 0 R 1385 0 R 1386 0 R 1387 0 R null null null
null 1388 0 R null null null null 1389 0 R 1390 0 R 1391 0 R 1392 0 R
1393 0 R 1394 0 R 1395 0 R 1396 0 R 1397 0 R 1398 0 R 1399 0 R]
10 [null null null 1400 0 R null null null 1401 0 R 1402 0 R 1403 0 R
1404 0 R 1405 0 R 1406 0 R 1407 0 R 1408 0 R]
11 [1409 0 R null 1410 0 R null 1411 0 R null null 1412 0 R null 1413 0 R
null null 1414 0 R null 1415 0 R null null 1416 0 R null 1417 0 R
null null 1418 0 R null 1419 0 R null 1420 0 R null null 1421 0 R
null 1422 0 R null null 1423 0 R null 1424 0 R null 1425 0 R null
1426 0 R 1427 0 R 1428 0 R 1429 0 R 1430 0 R 1431 0 R 1432 0 R 1433 0 R 1434 0 R 1435 0 R
1436 0 R 1437 0 R 1438 0 R 1439 0 R 1440 0 R 1441 0 R 1442 0 R 1443 0 R 1444 0 R 1445 0 R
1446 0 R 1447 0 R 1448 0 R 1449 0 R 1450 0 R 1451 0 R 1452 0 R 1453 0 R 1454 0 R 1455 0 R
1456 0 R 1457 0 R 1458 0 R 1459 0 R 1460 0 R 1461 0 R 1462 0 R 1463 0 R 1464 0 R 1465 0 R
1466 0 R 1467 0 R 1468 0 R 1469 0 R 1470 0 R 1471 0 R 1472 0 R 1473 0 R 1474 0 R 1475 0 R
1476 0 R 1477 0 R 1478 0 R 1479 0 R 1480 0 R 1481 0 R 1482 0 R 1483 0 R 1484 0 R 1485 0 R
1486 0 R 1487 0 R 1488 0 R 1489 0 R 1490 0 R 1491 0 R 1492 0 R 1493 0 R 1494 0 R 1495 0 R
1496 0 R 1497 0 R 1498 0 R 1499 0 R 1500 0 R 1501 0 R 1502 0 R 1503 0 R 1504 0 R 1505 0 R
1506 0 R 1507 0 R 1508 0 R 1509 0 R 1510 0 R 1511 0 R null]
12 [null null null 1512 0 R null null null 1513 0 R 1514 0 R 1515 0 R
1516 0 R 1517 0 R null null null 1518 0 R null null null 1519 0 R
1520 0 R 1521 0 R 1522 0 R null]
13 [1523 0 R null null null 1524 0 R null null null 1525 0 R 1526 0 R
1527 0 R null null null null 1528 0 R null null null null
1529 0 R null null null null 1530 0 R null null null null
null 1531 0 R null null null 1532 0 R null null null null
null 1533 0 R null null null null null 1534 0 R null null
null 1535 0 R null null null null null null 1536 0 R 1537 0 R
1538 0 R]
14 [null null null 1539 0 R null null null 1540 0 R 1541 0 R 1542 0 R
1543 0 R 1544 0 R null null null 1545 0 R null null null 1546 0 R
1547 0 R 1548 0 R]
15 [1549 0 R null null null 1550 0 R null null null 1551 0 R null
null 1552 0 R null null null 1553 0 R null null null null
1554 0 R null null null 1555 0 R null null null null 1556 0 R
null null null 1557 0 R null null 1558 0 R 1559 0 R]
16 [1560 0 R null null null 1561 0 R null null null 1562 0 R 1563 0 R
1564 0 R null null null null 1565 0 R null null null null
null 1566 0 R null null null null null null 1567 0 R 1568 0 R
null null null null null null 1569 0 R null null null
null null 1570 0 R null null null null null 1571 0 R null
null null 1572 0 R null null null null null null 1573 0 R
1574 0 R 1575 0 R 1576 0 R]
17 [1577 0 R 1578 0 R null null null 1579 0 R null null null 1580 0 R
1581 0 R 1582 0 R null null null null null null 1583 0 R null
null null 1584 0 R null null null null null null 1585 0 R
null null null 1586 0 R 1587 0 R 1588 0 R null null null null
null null 1589 0 R null null null 1590 0 R null null null
null null null 1591 0 R]
18 [1592 0 R null null null 1593 0 R null null null 1594 0 R 1595 0 R
1596 0 R null null null 1597 0 R null null null 1598 0 R 1599 0 R
1600 0 R 1601 0 R 1602 0 R 1603 0 R 1604 0 R 1605 0 R 1606 0 R 1607 0 R]
19 [1608 0 R 1609 0 R 1610 0 R 1611 0 R 1612 0 R 1613 0 R 1614 0 R 1615 0 R 1616 0 R null
null 1617 0 R null null 1618 0 R null null 1619 0 R null null
1620 0 R 1621 0 R 1622 0 R 1623 0 R 1624 0 R null 1625 0 R null null 1626 0 R
null null 1627 0 R null null 1628 0 R null 1629 0 R null 1630 0 R
null 1631 0 R 1632 0 R 1633 0 R 1634 0 R null 1635 0 R null 1636 0 R 1637 0 R
1638 0 R 1639 0 R 1640 0 R]
20 [null null null 1641 0 R null null null 1642 0 R 1643 0 R 1644 0 R
null null null 1645 0 R null null null 1646 0 R 1647 0 R 1648 0 R]
21 [1649 0 R null null null 1650 0 R null null null 1651 0 R 1652 0 R
1653 0 R 1654 0 R 1655 0 R 1656 0 R 1657 0 R 1658 0 R 1659 0 R null null null
1660 0 R null null null null 1661 0 R null null 1662 0 R null
1663 0 R null 1664 0 R null 1665 0 R 1666 0 R null 1667 0 R null 1668 0 R
1669 0 R null 1670 0 R null 1671 0 R 1672 0 R null 1673 0 R null 1674 0 R
1675 0 R 1676 0 R null null null 1677 0 R null null null 1678 0 R]
22 [1679 0 R null null null 1680 0 R null null null 1681 0 R 1682 0 R
1683 0 R 1684 0 R 1685 0 R null null null 1686 0 R null null null
1687 0 R 1688 0 R 1689 0 R 1690 0 R 1691 0 R 1692 0 R 1693 0 R 1694 0 R 1695 0 R 1696 0 R
1697 0 R]
23 [null null null 1698 0 R null null null 1699 0 R 1700 0 R 1701 0 R
null null null null 1702 0 R null null null null 1703 0 R
1704 0 R 1705 0 R 1706 0 R 1707 0 R 1708 0 R 1709 0 R 1710 0 R 1711 0 R 1712 0 R 1713 0 R]
24 [null null null null 1714 0 R null null null null 1715 0 R
null null null null 1716 0 R null null null 1717 0 R null
null null null 1718 0 R null null null null 1719 0 R null
null null 1720 0 R null null null null 1721 0 R null null
null null 1722 0 R null null null 1723 0 R null null null
null null 1724 0 R null null null null null 1725 0 R null
null null 1726 0 R null null null 1727 0 R null null null
1728 0 R null null null 1729 0 R null null null 1730 0 R null
null null null null null 1731 0 R 1732 0 R null null null
null 1733 0 R null null null null 1734 0 R 1735 0 R]
25 [null null null null 1736 0 R null null null null 1737 0 R
1738 0 R null null null 1739 0 R null null null 1740 0 R 1741 0 R
1742 0 R 1743 0 R 1744 0 R 1745 0 R 1746 0 R 1747 0 R 1748 0 R 1749 0 R 1750 0 R 1751 0 R]
26 [null null null 1752 0 R null null null 1753 0 R 1754 0 R 1755 0 R
1756 0 R 1757 0 R 1758 0 R 1759 0 R 1760 0 R 1761 0 R 1762 0 R 1763 0 R 1764 0 R]
27 [null null null 1765 0 R null null null 1766 0 R 1767 0 R 1768 0 R
1769 0 R 1770 0 R 1771 0 R 1772 0 R 1773 0 R null null null 1774 0 R null
null null 1775 0 R 1776 0 R 1777 0 R null null null null 1778 0 R
null null null null null 1779 0 R null null null 1780 0 R
null null null 1781 0 R null null null null null null
1782 0 R]
28 [1783 0 R null null null null null 1784 0 R null null null
null null 1785 0 R null null null null null 1786 0 R null
null null null 1787 0 R null null null 1788 0 R null null
null null 1789 0 R null null null null 1790 0 R null null
null 1791 0 R null null null null null 1792 0 R null null
null null null 1793 0 R null null null 1794 0 R null null
null null null 1795 0 R null null null null null 1796 0 R
null null null null null null 1797 0 R 1798 0 R null null
null null null null 1799 0 R null null null null null
null]
29 [null null null 1800 0 R null null null 1801 0 R 1802 0 R 1803 0 R
1804 0 R 1805 0 R null null null 1806 0 R null null null 1807 0 R
1808 0 R 1809 0 R null null null null 1810 0 R null null null
null null 1811 0 R null null null 1812 0 R null null null
null null null 1813 0 R 1814 0 R 1815 0 R]
30 [1816 0 R null null null null null null 1817 0 R null null
null 1818 0 R null null null null null null 1819 0 R 1820 0 R
null null null null 1821 0 R null null null null null
1822 0 R null null null null null null 1823 0 R 1824 0 R null
null null null null null 1825 0 R null null null null
null null 1826 0 R null null null 1827 0 R 1828 0 R 1829 0 R 1830 0 R
1831 0 R]
31 [1832 0 R null null null 1833 0 R null null null 1834 0 R 1835 0 R
1836 0 R 1837 0 R 1838 0 R 1839 0 R null null null null 1840 0 R null
null null null null 1841 0 R null null null null null
null 1842 0 R 1843 0 R null null null null null null 1844 0 R
null null null null null 1845 0 R null null null null
1846 0 R null null null null 1847 0 R null null null null
null 1848 0 R null null null 1849 0 R null null null 1850 0 R
null null null null null null]
32 [1851 0 R 1852 0 R null null null 1853 0 R null null null 1854 0 R
1855 0 R null null null null null null 1856 0 R null null
null 1857 0 R null null null 1858 0 R null null null 1859 0 R
null null null null null null 1860 0 R 1861 0 R 1862 0 R 1863 0 R
1864 0 R 1865 0 R]
33 [null null null 1866 0 R null null null 1867 0 R 1868 0 R 1869 0 R
null null null null null null 1870 0 R null null null
1871 0 R null null null 1872 0 R null null null 1873 0 R null
null null null null null 1874 0 R 1875 0 R 1876 0 R 1877 0 R 1878 0 R]
34 [null null null 1879 0 R null null null 1880 0 R 1881 0 R 1882 0 R
1883 0 R 1884 0 R 1885 0 R 1886 0 R 1887 0 R 1888 0 R 1889 0 R 1890 0 R 1891 0 R 1892 0 R
1893 0 R 1894 0 R 1895 0 R 1896 0 R 1897 0 R 1898 0 R 1899 0 R]
35 [null null null 1900 0 R null null null 1901 0 R 1902 0 R 1903 0 R
1904 0 R null null null 1905 0 R null null null 1906 0 R 1907 0 R
1908 0 R 1909 0 R null null null 1910 0 R null null null 1911 0 R
1912 0 R 1913 0 R 1914 0 R 1915 0 R]
36 [null null null 1916 0 R null null null 1917 0 R 1918 0 R 1919 0 R
1920 0 R 1921 0 R 1922 0 R 1923 0 R 1924 0 R 1925 0 R null null null 1926 0 R
null null null 1927 0 R 1928 0 R 1929 0 R 1930 0 R 1931 0 R 1932 0 R 1933 0 R
1934 0 R 1935 0 R]
37 [1936 0 R null null null 1937 0 R null null null 1938 0 R 1939 0 R
1940 0 R 1941 0 R 1942 0 R 1943 0 R 1944 0 R 1945 0 R 1946 0 R 1947 0 R]
38 [null null null 1948 0 R null null null 1949 0 R 1950 0 R 1951 0 R
1952 0 R 1953 0 R 1954 0 R 1955 0 R 1956 0 R 1957 0 R null null null null
null null 1958 0 R null null null 1959 0 R null null null
1960 0 R null null null 1961 0 R null null null 1962 0 R null
null null 1963 0 R null null null null null null 1964 0 R
1965 0 R 1966 0 R]
39 [1967 0 R 1968 0 R 1969 0 R null null null null null null 1970 0 R
null null null 1971 0 R null null null null null null
1972 0 R 1973 0 R null null null 1974 0 R null null null 1975 0 R
1976 0 R 1977 0 R 1978 0 R 1979 0 R 1980 0 R 1981 0 R]
40 [1982 0 R 1983 0 R 1984 0 R null null null 1985 0 R null null null
1986 0 R 1987 0 R 1988 0 R 1989 0 R 1990 0 R]
41 [1991 0 R null null null 1992 0 R null null null 1993 0 R 1994 0 R
1995 0 R null null null null 1996 0 R null null null null
1997 0 R 1998 0 R 1999 0 R 2000 0 R 2001 0 R 2002 0 R 2003 0 R 2004 0 R 2005 0 R null
null null null 2006 0 R null null null null 2007 0 R 2008 0 R
2009 0 R null null null null 2010 0 R null null null null]
42 [null null null 2011 0 R null null null 2012 0 R 2013 0 R 2014 0 R
null null null null 2015 0 R null null null null 2016 0 R
2017 0 R 2018 0 R 2019 0 R 2020 0 R null null null null 2021 0 R null
null null null 2022 0 R 2023 0 R 2024 0 R 2025 0 R 2026 0 R 2027 0 R null
null null 2028 0 R null null null 2029 0 R 2030 0 R 2031 0 R null
null null null null null 2032 0 R null null null 2033 0 R
null null null null null null]
43 [null null null 2034 0 R null null null 2035 0 R 2036 0 R 2037 0 R
2038 0 R 2039 0 R null null null 2040 0 R null null null 2041 0 R
2042 0 R 2043 0 R null null null null null null 2044 0 R null
null null 2045 0 R null null null 2046 0 R null null null
2047 0 R null null null 2048 0 R null null null null null
null 2049 0 R 2050 0 R 2051 0 R]
44 [null null null 2052 0 R null null null null null null
2053 0 R null null null 2054 0 R null null null 2055 0 R null
null null 2056 0 R null null null 2057 0 R null null null
2058 0 R null null null null null null 2059 0 R 2060 0 R null
null null 2061 0 R null null null 2062 0 R 2063 0 R 2064 0 R null
null null null 2065 0 R null null null null null 2066 0 R
null null null 2067 0 R null null null 2068 0 R null null
null 2069 0 R null null null null null null 2070 0 R 2071 0 R
null]
45 [null null null null 2072 0 R null null null null null
2073 0 R null null null 2074 0 R null null null 2075 0 R null
null null 2076 0 R null null null null null null 2077 0 R
2078 0 R null null null 2079 0 R null null null 2080 0 R 2081 0 R
null null null 2082 0 R null null null 2083 0 R 2084 0 R 2085 0 R
2086 0 R 2087 0 R 2088 0 R null null null null null null 2089 0 R
null null null 2090 0 R null null null null null null]
46 [null null null 2091 0 R null null null 2092 0 R 2093 0 R null
null null 2094 0 R null null null 2095 0 R 2096 0 R 2097 0 R 2098 0 R
null null null 2099 0 R null null null 2100 0 R 2101 0 R 2102 0 R
null null null 2103 0 R null null null 2104 0 R 2105 0 R 2106 0 R]
47 [2107 0 R 2108 0 R 2109 0 R null null null 2110 0 R null null null
2111 0 R 2112 0 R 2113 0 R 2114 0 R null null null 2115 0 R null null
null 2116 0 R 2117 0 R 2118 0 R null null null null 2119 0 R null
null null null null 2120 0 R null null null 2121 0 R null
null null 2122 0 R null null null null null null 2123 0 R
2124 0 R 2125 0 R]
48 [null null null null 2126 0 R null null null null 2127 0 R
2128 0 R 2129 0 R 2130 0 R 2131 0 R 2132 0 R 2133 0 R null null null null
2134 0 R null null null null 2135 0 R 2136 0 R null null null
null null null 2137 0 R null null null null null null
2138 0 R 2139 0 R null null null null null null 2140 0 R null
null null null null null 2141 0 R]
49 [2142 0 R 2143 0 R null null null 2144 0 R null null null 2145 0 R
2146 0 R null null null 2147 0 R null null null 2148 0 R 2149 0 R
2150 0 R null null null null 2151 0 R null null null null
null 2152 0 R null null null 2153 0 R null null null 2154 0 R
null null null null null null 2155 0 R 2156 0 R null null
null null 2157 0 R null null null null 2158 0 R 2159 0 R 2160 0 R
2161 0 R 2162 0 R 2163 0 R 2164 0 R]
50 [2165 0 R null null null null 2166 0 R null null null null
2167 0 R 2168 0 R 2169 0 R null null null null null null 2170 0 R
null null null null null null 2171 0 R 2172 0 R null null
null null null null 2173 0 R null null null null null
null 2174 0 R 2175 0 R 2176 0 R]
51 [2177 0 R null null null 2178 0 R null null null 2179 0 R 2180 0 R
2181 0 R 2182 0 R]
52 [2183 0 R null null null 2184 0 R null null null 2185 0 R 2186 0 R
2187 0 R null null null null null null 2188 0 R null null
null null null null 2189 0 R 2190 0 R 2191 0 R 2192 0 R 2193 0 R 2194 0 R
null null null null null null 2195 0 R null null null
null null null 2196 0 R null null null null null null
2197 0 R null null null 2198 0 R null null null null null
null 2199 0 R 2200 0 R 2201 0 R 2202 0 R 2203 0 R]
53 [null null null 2204 0 R null null null 2205 0 R 2206 0 R 2207 0 R]
54 [2208 0 R null null null 2209 0 R null null null 2210 0 R 2211 0 R
null null null 2212 0 R null null null 2213 0 R 2214 0 R 2215 0 R
2216 0 R 2217 0 R null null null 2218 0 R null null null 2219 0 R
2220 0 R 2221 0 R null null null null 2222 0 R null null null
null 2223 0 R 2224 0 R 2225 0 R 2226 0 R 2227 0 R 2228 0 R]
55 [null null null null 2229 0 R null null null null 2230 0 R
2231 0 R null null null null null null 2232 0 R null null
null 2233 0 R null null null null null null 2234 0 R 2235 0 R
2236 0 R 2237 0 R null null null 2238 0 R null null null 2239 0 R
2240 0 R 2241 0 R 2242 0 R 2243 0 R]
]
>>
endobj
398 0 obj
<<
/Annotation /Span
/Artifact /P
/Bibliography /BibEntry
/Chart /Figure
/Diagram /Figure
/DropCap /Figure
/Endnote /Note
/Footnote /Note
/InlineShape /Figure
/Outline /Span
/Strikeout /Span
/Subscript /Span
/Superscript /Span
/TextBox /Art
/Underline /Span
>>
endobj
399 0 obj
<<
/F 4
/MK <<
>>
/P 2244 0 R
/Parent 12 0 R
/Rect [112.652 740.977 233.379 757.029]
/Subtype /Widget
/Type /Annot
/AP 2245 0 R
>>
endobj
400 0 obj
<<
/F 4
/MK <<
>>
/P 454 0 R
/Parent 12 0 R
/Rect [113.247 740.77 233.974 756.821]
/Subtype /Widget
/Type /Annot
/AP 2246 0 R
>>
endobj
401 0 obj
<<
/F 4
/MK <<
>>
/P 471 0 R
/Parent 12 0 R
/Rect [112.454 741.166 233.181 757.218]
/Subtype /Widget
/Type /Annot
/AP 2247 0 R
>>
endobj
402 0 obj
<<
/F 4
/MK <<
>>
/P 489 0 R
/Parent 12 0 R
/Rect [112.454 740.77 233.181 756.821]
/Subtype /Widget
/Type /Annot
/AP 2248 0 R
>>
endobj
403 0 obj
<<
/F 4
/MK <<
>>
/P 2249 0 R
/Parent 12 0 R
/Rect [113.392 741.417 234.119 757.469]
/Subtype /Widget
/Type /Annot
/AP 2250 0 R
>>
endobj
404 0 obj
<<
/F 4
/MK <<
>>
/P 525 0 R
/Parent 12 0 R
/Rect [112.745 740.876 233.472 756.927]
/Subtype /Widget
/Type /Annot
/AP 2251 0 R
>>
endobj
405 0 obj
<<
/F 4
/MK <<
>>
/P 2252 0 R
/Parent 12 0 R
/Rect [112.89 742.713 233.617 758.764]
/Subtype /Widget
/Type /Annot
/AP 2253 0 R
>>
endobj
406 0 obj
<<
/F 4
/MK <<
>>
/P 536 0 R
/Parent 12 0 R
/Rect [113.035 742.171 233.762 758.222]
/Subtype /Widget
/Type /Annot
/AP 2254 0 R
>>
endobj
407 0 obj
<<
/F 4
/MK <<
>>
/P 2255 0 R
/Parent 12 0 R
/Rect [112.387 740.837 233.114 756.888]
/Subtype /Widget
/Type /Annot
/AP 2256 0 R
>>
endobj
408 0 obj
<<
/F 4
/MK <<
>>
/P 544 0 R
/Parent 12 0 R
/Rect [113.325 741.088 234.052 757.139]
/Subtype /Widget
/Type /Annot
/AP 2257 0 R
>>
endobj
409 0 obj
<<
/F 4
/MK <<
>>
/P 613 0 R
/Parent 12 0 R
/Rect [113.247 741.563 233.974 757.614]
/Subtype /Widget
/Type /Annot
/AP 2258 0 R
>>
endobj
410 0 obj
<<
/F 4
/MK <<
>>
/P 625 0 R
/Parent 12 0 R
/Rect [113.247 739.581 233.974 755.632]
/Subtype /Widget
/Type /Annot
/AP 2259 0 R
>>
endobj
411 0 obj
<<
/F 4
/MK <<
>>
/P 635 0 R
/Parent 12 0 R
/Rect [113.247 740.77 233.974 756.821]
/Subtype /Widget
/Type /Annot
/AP 2260 0 R
>>
endobj
412 0 obj
<<
/F 4
/MK <<
>>
/P 645 0 R
/Parent 12 0 R
/Rect [113.247 741.166 233.974 757.218]
/Subtype /Widget
/Type /Annot
/AP 2261 0 R
>>
endobj
413 0 obj
<<
/F 4
/MK <<
>>
/P 649 0 R
/Parent 12 0 R
/Rect [112.454 740.77 233.181 756.821]
/Subtype /Widget
/Type /Annot
/AP 2262 0 R
>>
endobj
414 0 obj
<<
/F 4
/MK <<
>>
/P 2263 0 R
/Parent 12 0 R
/Rect [113.247 739.977 233.974 756.028]
/Subtype /Widget
/Type /Annot
/AP 2264 0 R
>>
endobj
415 0 obj
<<
/F 4
/MK <<
>>
/P 665 0 R
/Parent 12 0 R
/Rect [112.454 741.166 233.181 757.218]
/Subtype /Widget
/Type /Annot
/AP 2265 0 R
>>
endobj
416 0 obj
<<
/F 4
/MK <<
>>
/P 681 0 R
/Parent 12 0 R
/Rect [113.04 741.355 233.767 757.407]
/Subtype /Widget
/Type /Annot
/AP 2266 0 R
>>
endobj
417 0 obj
<<
/F 4
/MK <<
>>
/P 693 0 R
/Parent 12 0 R
/Rect [113.247 741.959 233.974 758.01]
/Subtype /Widget
/Type /Annot
/AP 2267 0 R
>>
endobj
418 0 obj
<<
/F 4
/MK <<
>>
/P 710 0 R
/Parent 12 0 R
/Rect [112.454 741.355 233.181 757.407]
/Subtype /Widget
/Type /Annot
/AP 2268 0 R
>>
endobj
419 0 obj
<<
/F 4
/MK <<
>>
/P 722 0 R
/Parent 12 0 R
/Rect [113.247 741.166 233.974 757.218]
/Subtype /Widget
/Type /Annot
/AP 2269 0 R
>>
endobj
420 0 obj
<<
/F 4
/MK <<
>>
/P 746 0 R
/Parent 12 0 R
/Rect [113.091 740.938 233.818 756.989]
/Subtype /Widget
/Type /Annot
/AP 2270 0 R
>>
endobj
421 0 obj
<<
/F 4
/MK <<
>>
/P 782 0 R
/Parent 12 0 R
/Rect [112.873 742.084 233.599 758.135]
/Subtype /Widget
/Type /Annot
/AP 2271 0 R
>>
endobj
422 0 obj
<<
/F 4
/MK <<
>>
/P 784 0 R
/Parent 12 0 R
/Rect [113.418 741.265 234.145 757.317]
/Subtype /Widget
/Type /Annot
/AP 2272 0 R
>>
endobj
423 0 obj
<<
/F 4
/MK <<
>>
/P 807 0 R
/Parent 12 0 R
/Rect [113.091 741.593 233.818 757.644]
/Subtype /Widget
/Type /Annot
/AP 2273 0 R
>>
endobj
424 0 obj
<<
/F 4
/MK <<
>>
/P 822 0 R
/Parent 12 0 R
/Rect [112.727 740.647 233.454 756.698]
/Subtype /Widget
/Type /Annot
/AP 2274 0 R
>>
endobj
425 0 obj
<<
/F 4
/MK <<
>>
/P 830 0 R
/Parent 12 0 R
/Rect [112.764 740.774 233.491 756.826]
/Subtype /Widget
/Type /Annot
/AP 2275 0 R
>>
endobj
426 0 obj
<<
/F 4
/MK <<
>>
/P 841 0 R
/Parent 12 0 R
/Rect [112.764 740.774 233.491 756.826]
/Subtype /Widget
/Type /Annot
/AP 2276 0 R
>>
endobj
427 0 obj
<<
/F 4
/MK <<
>>
/P 852 0 R
/Parent 12 0 R
/Rect [113.255 741.429 233.982 757.48]
/Subtype /Widget
/Type /Annot
/AP 2277 0 R
>>
endobj
428 0 obj
<<
/F 4
/MK <<
>>
/P 860 0 R
/Parent 12 0 R
/Rect [113.091 740.774 233.818 756.826]
/Subtype /Widget
/Type /Annot
/AP 2278 0 R
>>
endobj
429 0 obj
<<
/F 4
/MK <<
>>
/P 872 0 R
/Parent 12 0 R
/Rect [112.764 741.593 233.491 757.644]
/Subtype /Widget
/Type /Annot
/AP 2279 0 R
>>
endobj
430 0 obj
<<
/F 4
/MK <<
>>
/P 888 0 R
/Parent 12 0 R
/Rect [112.927 740.774 233.654 756.826]
/Subtype /Widget
/Type /Annot
/AP 2280 0 R
>>
endobj
431 0 obj
<<
/F 4
/MK <<
>>
/P 895 0 R
/Parent 12 0 R
/Rect [112.764 740.447 233.491 756.498]
/Subtype /Widget
/Type /Annot
/AP 2281 0 R
>>
endobj
432 0 obj
<<
/F 4
/MK <<
>>
/P 934 0 R
/Parent 12 0 R
/Rect [113.091 742.083 233.818 758.135]
/Subtype /Widget
/Type /Annot
/AP 2282 0 R
>>
endobj
433 0 obj
<<
/F 4
/MK <<
>>
/P 946 0 R
/Parent 12 0 R
/Rect [112.436 740.92 233.163 756.971]
/Subtype /Widget
/Type /Annot
/AP 2283 0 R
>>
endobj
434 0 obj
<<
/F 4
/MK <<
>>
/P 959 0 R
/Parent 12 0 R
/Rect [113.418 740.938 234.145 756.989]
/Subtype /Widget
/Type /Annot
/AP 2284 0 R
>>
endobj
435 0 obj
<<
/F 4
/MK <<
>>
/P 972 0 R
/Parent 12 0 R
/Rect [112.764 740.938 233.491 756.989]
/Subtype /Widget
/Type /Annot
/AP 2285 0 R
>>
endobj
436 0 obj
<<
/F 4
/MK <<
>>
/P 977 0 R
/Parent 12 0 R
/Rect [112.872 741.865 233.599 757.917]
/Subtype /Widget
/Type /Annot
/AP 2286 0 R
>>
endobj
437 0 obj
<<
/F 4
/MK <<
>>
/P 992 0 R
/Parent 12 0 R
/Rect [112.872 741.429 233.599 757.48]
/Subtype /Widget
/Type /Annot
/AP 2287 0 R
>>
endobj
438 0 obj
<<
/F 4
/MK <<
>>
/P 1005 0 R
/Parent 12 0 R
/Rect [113.309 741.083 234.036 757.135]
/Subtype /Widget
/Type /Annot
/AP 2288 0 R
>>
endobj
439 0 obj
<<
/F 4
/MK <<
>>
/P 1015 0 R
/Parent 12 0 R
/Rect [112.745 741.265 233.472 757.317]
/Subtype /Widget
/Type /Annot
/AP 2289 0 R
>>
endobj
440 0 obj
<<
/F 4
/MK <<
>>
/P 1036 0 R
/Parent 12 0 R
/Rect [113.545 741.429 234.272 757.48]
/Subtype /Widget
/Type /Annot
/AP 2290 0 R
>>
endobj
441 0 obj
<<
/F 4
/MK <<
>>
/P 1052 0 R
/Parent 12 0 R
/Rect [112.6 742.247 233.327 758.298]
/Subtype /Widget
/Type /Annot
/AP 2291 0 R
>>
endobj
442 0 obj
<<
/F 4
/MK <<
>>
/P 1065 0 R
/Parent 12 0 R
/Rect [112.436 740.92 233.163 756.971]
/Subtype /Widget
/Type /Annot
/AP 2292 0 R
>>
endobj
443 0 obj
<<
/F 4
/MK <<
>>
/P 1079 0 R
/Parent 12 0 R
/Rect [112.746 741.101 233.473 757.153]
/Subtype /Widget
/Type /Annot
/AP 2293 0 R
>>
endobj
444 0 obj
<<
/F 4
/MK <<
>>
/P 1088 0 R
/Parent 12 0 R
/Rect [112.128 741.429 232.855 757.48]
/Subtype /Widget
/Type /Annot
/AP 2294 0 R
>>
endobj
445 0 obj
<<
/F 4
/MK <<
>>
/P 1098 0 R
/Parent 12 0 R
/Rect [113.092 741.756 233.819 757.807]
/Subtype /Widget
/Type /Annot
/AP 2295 0 R
>>
endobj
446 0 obj
<<
/F 4
/MK <<
>>
/P 1125 0 R
/Parent 12 0 R
/Rect [112.436 741.429 233.163 757.48]
/Subtype /Widget
/Type /Annot
/AP 2296 0 R
>>
endobj
447 0 obj
<<
/F 4
/MK <<
>>
/P 1143 0 R
/Parent 12 0 R
/Rect [112.764 741.429 233.491 757.48]
/Subtype /Widget
/Type /Annot
/AP 2297 0 R
>>
endobj
448 0 obj
<<
/F 4
/MK <<
>>
/P 1149 0 R
/Parent 12 0 R
/Rect [112.273 740.938 233.0 756.989]
/Subtype /Widget
/Type /Annot
/AP 2298 0 R
>>
endobj
449 0 obj
<<
/F 4
/MK <<
>>
/P 1155 0 R
/Parent 12 0 R
/Rect [113.218 741.302 233.945 757.353]
/Subtype /Widget
/Type /Annot
/AP 2299 0 R
>>
endobj
450 0 obj
<<
/F 4
/MK <<
>>
/P 1161 0 R
/Parent 12 0 R
/Rect [112.436 742.083 233.163 758.135]
/Subtype /Widget
/Type /Annot
/AP 2300 0 R
>>
endobj
451 0 obj
<<
/F 4
/MK <<
>>
/P 1185 0 R
/Parent 12 0 R
/Rect [112.855 741.338 233.582 757.389]
/Subtype /Widget
/Type /Annot
/AP 2301 0 R
>>
endobj
452 0 obj
<<
/F 4
/MK <<
>>
/P 1193 0 R
/Parent 12 0 R
/Rect [112.818 740.72 233.545 756.771]
/Subtype /Widget
/Type /Annot
/AP 2302 0 R
>>
endobj
453 0 obj
<<
/F 4
/MK <<
>>
/P 1197 0 R
/Parent 12 0 R
/Rect [114.06 741.379 234.787 757.43]
/Subtype /Widget
/Type /Annot
/AP 2303 0 R
>>
endobj
454 0 obj
<<
/Annots [400 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 461 0 R 462 0 R 463 0 R
20 0 R]
/Contents 2304 0 R
/CropBox [0.0 0.0 612.0 792.0]
/Group 2305 0 R
/MediaBox [0.0 0.0 612.0 792.0]
/Parent 1221 0 R
/Resources <<
/ColorSpace <<
/CS0 [/Indexed /DeviceRGB 0 2306 0 R]
>>
/ExtGState <<
/GS0 2307 0 R
>>
/Font <<
/C2_0 2308 0 R
/C2_1 2309 0 R
/TT0 2310 0 R
/TT1 2311 0 R
/TT2 2312 0 R
>>
/ProcSet [/PDF /Text /ImageC /ImageI]
/XObject <<
/Im0 2313 0 R
/Im1 2314 0 R
/Im2 2315 0 R
/Im3 2316 0 R
/Im4 2317 0 R
>>
>>
/Rotate 0
/StructParents 2
/Tabs /W
/Type /Page
>>
endobj
455 0 obj
<<
/N 2318 0 R
>>
endobj
456 0 obj
<<
/N 2319 0 R
>>
endobj
457 0 obj
<<
/N 2320 0 R
>>
endobj
458 0 obj
<<
/N 2321 0 R
>>
endobj
459 0 obj
<<
/N 2322 0 R
>>
endobj
460 0 obj
<<
/N 2323 0 R
>>
endobj
461 0 obj
<<
/AP <<
/D <<
/Off 2324 0 R
/State-Operated 2325 0 R
>>
/N <<
/State-Operated 2326 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 454 0 R
/Parent 19 0 R
/Rect [126.338 257.202 139.658 267.642]
/Subtype /Widget
/Type /Annot
>>
endobj
462 0 obj
<<
/AP <<
/D <<
/Contractor 2327 0 R
/Off 2328 0 R
>>
/N <<
/Contractor 2329 0 R
>>
>>
/AS /Contractor
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 454 0 R
/Parent 19 0 R
/Rect [126.338 237.202 139.658 247.642]
/Subtype /Widget
/Type /Annot
>>
endobj
463 0 obj
<<
/AP <<
/D <<
/Off 2330 0 R
/Other 2331 0 R
>>
/N <<
/Other 2332 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 454 0 R
/Parent 19 0 R
/Rect [126.338 216.202 139.658 226.642]
/Subtype /Widget
/Type /Annot
>>
endobj
464 0 obj
<<
/N 2333 0 R
>>
endobj
465 0 obj
<<
/AP <<
/D <<
/Off 2334 0 R
/POS#20vendor#20is#20the#20fiscal#20agent 2335 0 R
>>
/N <<
/POS#20vendor#20is#20the#20fiscal#20agent 2336 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 471 0 R
/Parent 21 0 R
/Rect [166.338 668.936 179.658 679.376]
/Subtype /Widget
/Type /Annot
>>
endobj
466 0 obj
<<
/AP <<
/D <<
/Off 2337 0 R
/POS#20vendor#20is#20a#20separate#20PBM 2338 0 R
>>
/N <<
/POS#20vendor#20is#20a#20separate#20PBM 2339 0 R
>>
>>
/AS /POS#20vendor#20is#20a#20separate#20PBM
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 471 0 R
/Parent 21 0 R
/Rect [166.338 645.936 179.658 656.376]
/Subtype /Widget
/Type /Annot
>>
endobj
467 0 obj
<<
/AP <<
/D <<
/No 2340 0 R
/Off 2341 0 R
>>
/N <<
/No 2342 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 471 0 R
/Parent 21 0 R
/Rect [166.158 622.756 179.838 633.556]
/Subtype /Widget
/Type /Annot
>>
endobj
468 0 obj
<<
/Length 34
/BBox [0.0 0.0 13.32 10.4399]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.32 10.4399 re
f
endstream
endobj
469 0 obj
<<
/Length 92
/BBox [0.0 0.0 13.32 10.4399]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
H237402VH2P0P0436R0431T(JJ*2T BC\<+A!ȝX&ega`a@\\ |Ll
endstream
endobj
470 0 obj
<<
/Length 70
/BBox [0.0 0.0 13.32 10.4399]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
H*2T BC=c#=cKKTp<.L; L.RBH! -
endstream
endobj
471 0 obj
<<
/Annots [401 0 R 465 0 R 466 0 R 467 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 482 0 R
483 0 R 28 0 R]
/Contents 2343 0 R
/CropBox [0.0 0.0 612.0 792.0]
/Group 2305 0 R
/MediaBox [0.0 0.0 612.0 792.0]
/Parent 1221 0 R
/Resources <<
/ColorSpace <<
/CS0 [/Indexed /DeviceRGB 0 2306 0 R]
>>
/ExtGState <<
/GS0 2307 0 R
>>
/Font <<
/C2_0 2308 0 R
/C2_1 2309 0 R
/C2_2 2344 0 R
/C2_3 2345 0 R
/TT0 2310 0 R
/TT1 2311 0 R
/TT2 2346 0 R
>>
/ProcSet [/PDF /Text /ImageC /ImageI]
/XObject <<
/Im0 2347 0 R
/Im1 2315 0 R
/Im2 2348 0 R
>>
>>
/Rotate 0
/StructParents 3
/Tabs /W
/Type /Page
>>
endobj
472 0 obj
<<
/Length 34
/BBox [0.0 0.0 13.32 10.4399]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.32 10.4399 re
f
endstream
endobj
473 0 obj
<<
/Length 92
/BBox [0.0 0.0 13.32 10.4399]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
H237402VH2P0P0436R0431T(JJ*2T BC\<+A!ȝX&ega`a@\\ |Ll
endstream
endobj
474 0 obj
<<
/Length 70
/BBox [0.0 0.0 13.32 10.4399]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
H*2T BC=c#=cKKTp<.L; L.RBH! -
endstream
endobj
475 0 obj
<<
/Length 34
/BBox [0.0 0.0 13.32 10.4399]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.32 10.4399 re
f
endstream
endobj
476 0 obj
<<
/Length 92
/BBox [0.0 0.0 13.32 10.4399]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
H237402VH2P0P0436R0431T(JJ*2T BC\<+A!ȝX&ega`a@\\ |Ll
endstream
endobj
477 0 obj
<<
/Length 70
/BBox [0.0 0.0 13.32 10.4399]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
H*2T BC=c#=cKKTp<.L; L.RBH! -
endstream
endobj
478 0 obj
<<
/Length 34
/BBox [0.0 0.0 13.32 10.4399]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.32 10.4399 re
f
endstream
endobj
479 0 obj
<<
/Length 92
/BBox [0.0 0.0 13.32 10.4399]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
H237402VH2P0P0436R0431T(JJ*2T BC\<+A!ȝX&ega`a@\\ |Ll
endstream
endobj
480 0 obj
<<
/Length 70
/BBox [0.0 0.0 13.32 10.4399]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
H*2T BC=c#=cKKTp<.L; L.RBH! -
endstream
endobj
481 0 obj
<<
/Length 147
/BBox [0.0 0.0 395.073 73.179]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
/Font 2349 0 R
>>
/Subtype /Form
/Type /XObject
>>
stream
xU
0sK~C5Ń6zP4 >IK),|;#si8dhB9Cgv+bo{(,շE-fb͐phטc,z@Ԋ/ԫz
M+"/B
endstream
endobj
482 0 obj
<<
/AP <<
/D <<
/Off 2350 0 R
/Yes 2351 0 R
>>
/N <<
/Yes 2352 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 471 0 R
/Parent 27 0 R
/Rect [126.338 336.523 139.658 346.963]
/Subtype /Widget
/Type /Annot
>>
endobj
483 0 obj
<<
/AP <<
/D <<
/No 2353 0 R
/Off 2354 0 R
>>
/N <<
/No 2355 0 R
>>
>>
/AS /No
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 471 0 R
/Parent 27 0 R
/Rect [126.338 315.523 139.658 325.963]
/Subtype /Widget
/Type /Annot
>>
endobj
484 0 obj
<<
/Length 343
/BBox [0.0 0.0 396.668 72.127]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
/Font 2356 0 R
>>
/Subtype /Form
/Type /XObject
>>
stream
xR=o0Wxl$QjUgFCSлw#ٙKߘCAL@JRsID1LgdoKHd}[Lc IMl'(*HMa &WW{MZ;ܓ̳&<'2ʓKߚaë́(*~vvz|y4ƽ>gqXg]vcrGtF8\궦U_B,'x_ڵsaÅЂ
"ͯEMEBɎ;.i1[bJ]k%T-R~~ E@
endstream
endobj
485 0 obj
<<
/AP <<
/D <<
/Off 2357 0 R
/Yes 2358 0 R
>>
/N <<
/Yes 2359 0 R
>>
>>
/AS /Yes
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 489 0 R
/Parent 29 0 R
/Rect [125.921 634.885 139.241 645.325]
/Subtype /Widget
/Type /Annot
>>
endobj
486 0 obj
<<
/AP <<
/D <<
/No 2360 0 R
/Off 2361 0 R
>>
/N <<
/No 2362 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 489 0 R
/Parent 29 0 R
/Rect [125.921 613.805 139.241 624.245]
/Subtype /Widget
/Type /Annot
>>
endobj
487 0 obj
<<
/AP <<
/D <<
/Off 2363 0 R
/Varies#20by#20alert#20type 2364 0 R
>>
/N <<
/Varies#20by#20alert#20type 2365 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 489 0 R
/Parent 29 0 R
/Rect [125.921 593.588 139.241 604.028]
/Subtype /Widget
/Type /Annot
>>
endobj
488 0 obj
<<
/Length 148
/BBox [0.0 0.0 393.764 72.127]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
/Font 2366 0 R
>>
/Subtype /Form
/Type /XObject
>>
stream
xU
0sKj&x|A7i)Eeog6}n]:<eU] ^;
9C%ڐr̚C/! !hQ|'Vy^i53a2/XpxGqDS i/1
endstream
endobj
489 0 obj
<<
/Annots [402 0 R 485 0 R 486 0 R 487 0 R 30 0 R 1199 0 R 388 0 R 31 0 R 32 0 R 33 0 R
34 0 R 35 0 R]
/Contents 2367 0 R
/CropBox [0.0 0.0 612.0 792.0]
/Group 2305 0 R
/MediaBox [0.0 0.0 612.0 792.0]
/Parent 1221 0 R
/Resources <<
/ColorSpace <<
/CS0 [/Indexed /DeviceRGB 0 2306 0 R]
>>
/ExtGState <<
/GS0 2307 0 R
>>
/Font <<
/C2_0 2308 0 R
/C2_1 2309 0 R
/TT0 2310 0 R
/TT1 2346 0 R
>>
/ProcSet [/PDF /Text /ImageC /ImageI]
/XObject <<
/Im0 2368 0 R
/Im1 2369 0 R
/Im2 2317 0 R
>>
>>
/Rotate 0
/StructParents 4
/Tabs /W
/Type /Page
>>
endobj
490 0 obj
<<
/Length 32
/BBox [0.0 0.0 13.68 10.08]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.68 10.08 re
f
endstream
endobj
491 0 obj
<<
/Length 109
/BBox [0.0 0.0 13.68 10.08]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.68 10.08 re
f
q
1 1 11.68 8.08 re
W
n
0 0 1 RG
3.8 8.08 m
9.88 2 l
9.88 8.08 m
3.8 2 l
s
Q
endstream
endobj
492 0 obj
<<
/Length 77
/BBox [0.0 0.0 13.68 10.08]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
q
1 1 11.68 8.08 re
W
n
0 0 1 RG
3.8 8.08 m
9.88 2 l
9.88 8.08 m
3.8 2 l
s
Q
endstream
endobj
493 0 obj
<<
/Length 32
/BBox [0.0 0.0 13.68 10.08]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.68 10.08 re
f
endstream
endobj
494 0 obj
<<
/Length 109
/BBox [0.0 0.0 13.68 10.08]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.68 10.08 re
f
q
1 1 11.68 8.08 re
W
n
0 0 1 RG
3.8 8.08 m
9.88 2 l
9.88 8.08 m
3.8 2 l
s
Q
endstream
endobj
495 0 obj
<<
/Length 77
/BBox [0.0 0.0 13.68 10.08]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
q
1 1 11.68 8.08 re
W
n
0 0 1 RG
3.8 8.08 m
9.88 2 l
9.88 8.08 m
3.8 2 l
s
Q
endstream
endobj
496 0 obj
<<
/Length 33
/BBox [0.0 0.0 13.68 10.079]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.68 10.079 re
f
endstream
endobj
497 0 obj
<<
/Length 123
/BBox [0.0 0.0 13.68 10.079]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.68 10.079 re
f
q
1 1 11.68 8.079 re
W
n
0 0 1 RG
3.8005 8.079 m
9.8795 2 l
9.8795 8.079 m
3.8005 2 l
s
Q
endstream
endobj
498 0 obj
<<
/Length 90
/BBox [0.0 0.0 13.68 10.079]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
q
1 1 11.68 8.079 re
W
n
0 0 1 RG
3.8005 8.079 m
9.8795 2 l
9.8795 8.079 m
3.8005 2 l
s
Q
endstream
endobj
499 0 obj
<<
/Length 32
/BBox [0.0 0.0 13.68 10.08]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.68 10.08 re
f
endstream
endobj
500 0 obj
<<
/Length 109
/BBox [0.0 0.0 13.68 10.08]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
0.749023 g
0 0 13.68 10.08 re
f
q
1 1 11.68 8.08 re
W
n
0 0 1 RG
3.8 8.08 m
9.88 2 l
9.88 8.08 m
3.8 2 l
s
Q
endstream
endobj
501 0 obj
<<
/Length 77
/BBox [0.0 0.0 13.68 10.08]
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
>>
/Subtype /Form
/Type /XObject
>>
stream
q
1 1 11.68 8.08 re
W
n
0 0 1 RG
3.8 8.08 m
9.88 2 l
9.88 8.08 m
3.8 2 l
s
Q
endstream
endobj
502 0 obj
<<
/Length 147
/BBox [0.0 0.0 360.561 54.656]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
/Font 2370 0 R
>>
/Subtype /Form
/Type /XObject
>>
stream
xU
0DsK6ݨĢڀP#Aт6-²3Fo֦γP0O:J9q|'\g{h`J8&JV6cN:~x
+RN3zar^*.#/5
endstream
endobj
503 0 obj
<<
/AP <<
/D <<
/Off 2371 0 R
/Yes 2372 0 R
>>
/N <<
/Yes 2373 0 R
>>
>>
/AS /Yes
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 36 0 R
/Rect [161.278 645.638 174.718 656.078]
/Subtype /Widget
/Type /Annot
>>
endobj
504 0 obj
<<
/AP <<
/D <<
/No 2374 0 R
/Off 2375 0 R
>>
/N <<
/No 2376 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 36 0 R
/Rect [161.278 622.718 174.718 633.158]
/Subtype /Widget
/Type /Annot
>>
endobj
505 0 obj
<<
/AP <<
/D <<
/Dependent#20on#20medication#20or#20situation 2377 0 R
/Off 2378 0 R
>>
/N <<
/Dependent#20on#20medication#20or#20situation 2379 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 36 0 R
/Rect [161.278 599.152 174.718 609.592]
/Subtype /Widget
/Type /Annot
>>
endobj
506 0 obj
<<
/AP <<
/D <<
/Off 2380 0 R
/Pharmacist 2381 0 R
>>
/N <<
/Pharmacist 2382 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 37 0 R
/Rect [180.278 537.132 193.718 547.572]
/Subtype /Widget
/Type /Annot
>>
endobj
507 0 obj
<<
/AP <<
/D <<
/Off 2383 0 R
/Prescriber 2384 0 R
>>
/N <<
/Prescriber 2385 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 37 0 R
/Rect [180.278 513.212 193.718 523.652]
/Subtype /Widget
/Type /Annot
>>
endobj
508 0 obj
<<
/AP <<
/D <<
/Off 2386 0 R
/Pharmacist#20or#20Prescriber 2387 0 R
>>
/N <<
/Pharmacist#20or#20Prescriber 2388 0 R
>>
>>
/AS /Pharmacist#20or#20Prescriber
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 37 0 R
/Rect [180.278 488.172 193.718 498.612]
/Subtype /Widget
/Type /Annot
>>
endobj
509 0 obj
<<
/AP <<
/D <<
/Off 2389 0 R
/Yes 2390 0 R
>>
/N <<
/Yes 2391 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 38 0 R
/Rect [180.278 425.25 193.718 435.69]
/Subtype /Widget
/Type /Annot
>>
endobj
510 0 obj
<<
/AP <<
/D <<
/No 2392 0 R
/Off 2393 0 R
>>
/N <<
/No 2394 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 38 0 R
/Rect [180.278 402.21 193.718 412.65]
/Subtype /Widget
/Type /Annot
>>
endobj
511 0 obj
<<
/AP <<
/D <<
/Off 2395 0 R
/Yes 2396 0 R
>>
/N <<
/Yes 2397 0 R
>>
>>
/AS /Yes
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 39 0 R
/Rect [162.338 300.537 175.658 310.977]
/Subtype /Widget
/Type /Annot
>>
endobj
512 0 obj
<<
/AP <<
/D <<
/No 2398 0 R
/Off 2399 0 R
>>
/N <<
/No 2400 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 39 0 R
/Rect [162.338 277.971 175.658 288.411]
/Subtype /Widget
/Type /Annot
>>
endobj
513 0 obj
<<
/AP <<
/D <<
/Off 2401 0 R
/Pharmacist 2402 0 R
>>
/N <<
/Pharmacist 2403 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 40 0 R
/Rect [175.278 216.131 188.718 226.571]
/Subtype /Widget
/Type /Annot
>>
endobj
514 0 obj
<<
/AP <<
/D <<
/Off 2404 0 R
/Prescriber 2405 0 R
>>
/N <<
/Prescriber 2406 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 40 0 R
/Rect [175.278 193.211 188.718 203.651]
/Subtype /Widget
/Type /Annot
>>
endobj
515 0 obj
<<
/AP <<
/D <<
/Off 2407 0 R
/Pharmacist#20or#20Prescriber 2408 0 R
>>
/N <<
/Pharmacist#20or#20Prescriber 2409 0 R
>>
>>
/AS /Pharmacist#20or#20Prescriber
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 40 0 R
/Rect [175.278 170.171 188.718 180.611]
/Subtype /Widget
/Type /Annot
>>
endobj
516 0 obj
<<
/AP <<
/D <<
/Off 2410 0 R
/Yes 2411 0 R
>>
/N <<
/Yes 2412 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 41 0 R
/Rect [176.278 109.611 189.718 120.051]
/Subtype /Widget
/Type /Annot
>>
endobj
517 0 obj
<<
/AP <<
/D <<
/No 2413 0 R
/Off 2414 0 R
>>
/N <<
/No 2415 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2249 0 R
/Parent 41 0 R
/Rect [176.278 86.6907 189.718 97.1307]
/Subtype /Widget
/Type /Annot
>>
endobj
518 0 obj
<<
/AP <<
/D <<
/Off 2416 0 R
/Yes 2417 0 R
>>
/N <<
/Yes 2418 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 525 0 R
/Parent 42 0 R
/Rect [166.278 626.885 179.718 637.325]
/Subtype /Widget
/Type /Annot
>>
endobj
519 0 obj
<<
/AP <<
/D <<
/No 2419 0 R
/Off 2420 0 R
>>
/N <<
/No 2421 0 R
>>
>>
/AS /No
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 525 0 R
/Parent 42 0 R
/Rect [166.278 603.885 179.718 614.325]
/Subtype /Widget
/Type /Annot
>>
endobj
520 0 obj
<<
/AP <<
/D <<
/Off 2422 0 R
/Overrides#20are#20only#20allowed#20by#20a#20pharmacist#20through#20a#20prior#20authorization 2423 0 R
>>
/N <<
/Overrides#20are#20only#20allowed#20by#20a#20pharmacist#20through#20a#20prior#20authorization 2424 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 525 0 R
/Parent 42 0 R
/Rect [166.278 581.885 179.718 592.325]
/Subtype /Widget
/Type /Annot
>>
endobj
521 0 obj
<<
/AP <<
/D <<
/Off 2425 0 R
/Yes 2426 0 R
>>
/N <<
/Yes 2427 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 525 0 R
/Parent 43 0 R
/Rect [166.778 518.885 180.218 529.325]
/Subtype /Widget
/Type /Annot
>>
endobj
522 0 obj
<<
/AP <<
/D <<
/No 2428 0 R
/Off 2429 0 R
>>
/N <<
/No 2430 0 R
>>
>>
/AS /No
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 525 0 R
/Parent 43 0 R
/Rect [166.778 495.885 180.218 506.325]
/Subtype /Widget
/Type /Annot
>>
endobj
523 0 obj
<<
/AP <<
/D <<
/Off 2431 0 R
/Overrides#20are#20only#20allowed#20by#20a#20pharmacist#20through#20a#20prior#20authorization 2432 0 R
>>
/N <<
/Overrides#20are#20only#20allowed#20by#20a#20pharmacist#20through#20a#20prior#20authorization 2433 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 525 0 R
/Parent 43 0 R
/Rect [166.778 472.885 180.218 483.325]
/Subtype /Widget
/Type /Annot
>>
endobj
524 0 obj
<<
/Length 149
/BBox [0.0 0.0 398.308 61.4622]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
/Font 2434 0 R
>>
/Subtype /Form
/Type /XObject
>>
stream
xU
0sK$5Ń6zP >MYXe>
hz(*u%
UiQ:cJ@.rY]3~mG`5d09M[ϙrZ1džаf,66t/
endstream
endobj
525 0 obj
<<
/Annots [404 0 R 518 0 R 519 0 R 520 0 R 521 0 R 522 0 R 523 0 R 44 0 R 526 0 R 527 0 R
46 0 R]
/Contents 2435 0 R
/CropBox [0.0 0.0 612.0 792.0]
/Group 2305 0 R
/MediaBox [0.0 0.0 612.0 792.0]
/Parent 1222 0 R
/Resources <<
/ColorSpace <<
/CS0 [/Indexed /DeviceRGB 0 2306 0 R]
>>
/ExtGState <<
/GS0 2307 0 R
>>
/Font <<
/C2_0 2308 0 R
/C2_1 2309 0 R
/TT0 2310 0 R
/TT1 2346 0 R
>>
/ProcSet [/PDF /Text /ImageC /ImageI]
/XObject <<
/Im0 2436 0 R
/Im1 2317 0 R
/Im2 2347 0 R
/Im3 2437 0 R
/Im4 2438 0 R
>>
>>
/Rotate 0
/StructParents 7
/Tabs /W
/Type /Page
>>
endobj
526 0 obj
<<
/AP <<
/D <<
/Off 2439 0 R
/Yes 2440 0 R
>>
/N <<
/Yes 2441 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 525 0 R
/Parent 45 0 R
/Rect [126.338 270.252 139.659 280.692]
/Subtype /Widget
/Type /Annot
>>
endobj
527 0 obj
<<
/AP <<
/D <<
/No 2442 0 R
/Off 2443 0 R
>>
/N <<
/No 2444 0 R
>>
>>
/AS /No
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 525 0 R
/Parent 45 0 R
/Rect [126.338 249.514 139.659 259.954]
/Subtype /Widget
/Type /Annot
>>
endobj
528 0 obj
<<
/Length 148
/BBox [0.0 0.0 395.455 68.031]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
/Font 2445 0 R
>>
/Subtype /Form
/Type /XObject
>>
stream
xU
0sK~Lkbыm)Aт&-²ϭc7@3AQVֲ
e4=b-,&jf;z5Lr\Ԋ//˭zBD+V\3?/!
endstream
endobj
529 0 obj
<<
/AP <<
/D <<
/Off 2446 0 R
/Yes 2447 0 R
>>
/N <<
/Yes 2448 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2252 0 R
/Parent 47 0 R
/Rect [144.278 679.917 157.718 690.357]
/Subtype /Widget
/Type /Annot
>>
endobj
530 0 obj
<<
/AP <<
/D <<
/No 2449 0 R
/Off 2450 0 R
>>
/N <<
/No 2451 0 R
>>
>>
/AS /No
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2252 0 R
/Parent 47 0 R
/Rect [144.278 659.111 157.718 669.551]
/Subtype /Widget
/Type /Annot
>>
endobj
531 0 obj
<<
/AP <<
/D <<
/Off 2452 0 R
/Yes 2453 0 R
>>
/N <<
/Yes 2454 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2252 0 R
/Parent 48 0 R
/Rect [126.338 565.591 139.659 576.031]
/Subtype /Widget
/Type /Annot
>>
endobj
532 0 obj
<<
/AP <<
/D <<
/No 2455 0 R
/Off 2456 0 R
>>
/N <<
/No 2457 0 R
>>
>>
/AS /No
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2252 0 R
/Parent 48 0 R
/Rect [126.338 544.817 139.659 555.257]
/Subtype /Widget
/Type /Annot
>>
endobj
533 0 obj
<<
/AP <<
/D <<
/Off 2458 0 R
/Yes 2459 0 R
>>
/N <<
/Yes 2460 0 R
>>
>>
/AS /Yes
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2252 0 R
/Parent 49 0 R
/Rect [126.338 420.238 139.659 430.678]
/Subtype /Widget
/Type /Annot
>>
endobj
534 0 obj
<<
/AP <<
/D <<
/No 2461 0 R
/Off 2462 0 R
>>
/N <<
/No 2463 0 R
>>
>>
/AS /Off
/BS <<
/S /S
/W 0
>>
/F 4
/MK <<
/CA (l)
>>
/P 2252 0 R
/Parent 49 0 R
/Rect [126.338 400.17 139.659 410.61]
/Subtype /Widget
/Type /Annot
>>
endobj
535 0 obj
<<
/Length 989
/BBox [0.0 0.0 395.455 68.0311]
/Filter /FlateDecode
/FormType 1
/Matrix [1.0 0.0 0.0 1.0 0.0 0.0]
/Resources <<
/ProcSet [/PDF]
/Font 2464 0 R
>>
/Subtype /Form
/Type /XObject
>>
stream
xVMo6WT$@͈cmouzɅ蘭-y))(&)ja F@ro{3RR?6O6זIf)9byr2qjuMu"OǟVsf"5I&*gJdI>y,Ln7$CئJn6;ަéahu[Zdv^ B9
͋=1
!;/.#,KUU<$-7.Ku
y#:DZ.=l[o a,v5_Ug| 'Kw` hQAD0FWOkBAsϽn; *F(|ʕLL
n"I]+UA8}YWno-vJc sI9.s1h;*xrȄ/M:ny"ʻ3$ewρ(SqTP